WO2019173866A1 - Sensory stimulation apparatus - Google Patents
Sensory stimulation apparatus Download PDFInfo
- Publication number
- WO2019173866A1 WO2019173866A1 PCT/AU2019/050219 AU2019050219W WO2019173866A1 WO 2019173866 A1 WO2019173866 A1 WO 2019173866A1 AU 2019050219 W AU2019050219 W AU 2019050219W WO 2019173866 A1 WO2019173866 A1 WO 2019173866A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- coil
- signals
- subject
- coils
- stimulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/004—Magnetotherapy specially adapted for a specific therapy
- A61N2/006—Magnetotherapy specially adapted for a specific therapy for magnetic stimulation of nerve tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/002—Magnetotherapy in combination with another treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/02—Magnetotherapy using magnetic fields produced by coils, including single turn loops or electromagnets
-
- G—PHYSICS
- G06—COMPUTING OR CALCULATING; COUNTING
- G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
- G06N20/00—Machine learning
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/025—Digital circuitry features of electrotherapy devices, e.g. memory, clocks, processors
Definitions
- the present invention relates to a method and apparatus for providing sensory stimulation, such as audible or visual stimulation, to a subject, and in one particular example, providing sensory stimulation by generating a stimulatory electromagnetic field to selectively activate sensory neurons.
- sensory stimulation such as audible or visual stimulation
- Neuromodulation has multiple applications in modem medicine. Some widely known applications include prosthetics i.e. devices that improve impaired sensory, motor or cognitive neural functions, devices to regulate the body’s organs in disease states through neural mechanisms, and investigation of neural functions in the peripheral and central nervous systems. These neuromodulation techniques influence the flow of ions through the neurons to either stimulate or block the firing of Action Potentials in the nerve. Traditionally, the main technique for neuromodulation has been the use of direct electric current which induces a potential or voltage gradient across the neuron. Once sufficient, this potential gradient allows the neuron to initiate or suppress an Action Potential depending on the intended effect. This technique was successfully demonstrated by the first cochlear implants. Another neuromodulation methodology has been the use of magnetic stimulation.
- Transcranial Magnetic Stimulators use magnetic pulses to induce an electric field across the neuron, which leads to the potential gradient required for modulation.
- Other neuromodulation techniques include optogenetics, thermal, acoustic/mechanical, and chemical neuromodulation.
- the World Health Organisation estimates that there are around 466 million people in the world that suffer from a disabling hearing loss. Moreover, the current production of hearing devices meets only 10% of this global need.
- different devices are prescribed to patients with hearing loss.
- the hearing system is made up of three parts where the outer ear or the pinna funnels the sound to the ear canal.
- the sound vibrations then fall upon the ear drum of the middle ear and are amplified through three tiny bones called the ossicles.
- the ossicles then transfer the vibrations into the cochlea placed in the inner ear.
- the cochlea is a spiral organ that resembles a snail’s shell. Inside the cochlea is the organ of corti, which contains hair cells. These hair cells sense the vibrations of the sound and convert them into action potentials that get transferred to spiral ganglion neurons attached to them.
- the spiral ganglion cells then bundle up to form the auditory nerve.
- Cochlear implants are prescribed when the hair cells of the patient are not working but the spiral ganglion neurons are still functional.
- the implant is placed inside the cochlea and injects currents which depolarise the spiral ganglion neurons and leads to a series of action potentials or spikes. These spikes are then carried to the brain to be processed as auditory information.
- the cochlear implant system can be broken down into a number of parts.
- the external processor placed behind the ear with a hook and a battery case uses a microphone to pick up the sounds from the environment. These sound waves are converted from analog to digital signals after which they are processed and encoded into a radiofrequency (RF) signal.
- RF radiofrequency
- a sealed stimulator contains active electronic circuits that derive power from the RF signal, decode it, convert it into electrical currents, and send them along wires leading to the cochlea.
- the electrodes at the end of the wires and inside the cochlea then stimulate the auditory nerve according to the sent electric signals.
- Cochlear implants require a highly invasive surgery where the doctor makes an incision behind the ear, drills insides the temporal bone of the skull, pushes the internal receiver under the skull and the electrode inside the cochlea.
- This surgery subjects the patient to multiple risks like infection, facial paralysis, vertigo, loss of taste, tinnitus, insertion trauma, and other risks associated with anesthesia.
- the procedure destroys any residual hearing, meaning there is a risk that the patients hearing will be worse, or at least lose some resolution, after the procedure.
- the procedure is not reversible, meaning this cannot be used temporarily, such as an in cases of temporary hearing loss, or to allow direct interface with devices, for example for use in virtual reality applications or similar.
- Transcranial Magnetic Stimulation has been used for anti-depression therapy, as well as to map the functionality of different areas of the brain, to treat tinnitus, therapy for Parkinson’s disease, Alzheimer’s disease, and most recently to stimulate retinal neurons.
- J. Y. Shin and J.-H. A,“Electrodeless, Non-Invasive Stimulation of Retinal Neurons Using Time-Varying Magnetic Fields,” IEEE Sensors Journal, vol. 16, no. 24, pp. 88832- 8840, 2016 describes a surgically non-invasive retinal stimulation method by using time- varying magnetic fields. Retinal stimulations are achieved by inducing eddy currents on retinal ganglion cells with time-varying magnetic fields.
- the stimulator is developed using a voltage source, a voltage booster, a trigger circuit, a driver circuit, a storage capacitor bank, and a stimulating coil.
- US20070260107 describes a system for Stereotactic Transcranial Magnetic Stimulation (sTMS) at predetermined locations with the brain or spinal cord and incorporates an array of electromagnets arranged in a specified configuration where selected coils in the array are pulsed simultaneously. Activation of foci demonstrated by functional MRI or other imaging techniques can be used to locate the neural region affected. Imaging techniques can also be utilized to determine the location of the designated targets.
- STMS Stereotactic Transcranial Magnetic Stimulation
- US20080046053 describes an apparatus for generating focused currents in biological tissue.
- the apparatus comprises an electric source capable of generating an electric field across a region of tissue and means for altering the permittivity of the tissue relative to the electric field, whereby a displacement current is generated.
- the means for altering the permittivity may be a chemical source, optical source, mechanical source, thermal source, or electromagnetic source.
- TMS Transcranial Magnetic Stimulation
- US-8,972,004 describes devices and systems for the non-invasive treatment of medical conditions through delivery of energy to target tissue, comprising a source of electrical power, a magnetically permeable toroidal core, and a coil that is wound around the core.
- the coil and core are embedded in a continuous electrically conducting medium, which is adapted to have a shape that conforms to the contour of an arbitrarily oriented target body surface of a patient.
- the conducting medium is applied to that surface by any of several disclosed methods, and the source of power supplies a pulse of electric charge to the coil, such that the coil induces an electric current and/or an electric field within the patient, thereby stimulating tissue and/or one or more nerve fibers within the patient.
- the invention shapes an elongated electric field of effect that can be oriented parallel to a long nerve.
- the device comprises two toroidal cores that lie adjacent to one another.
- US2011/0029044 describes a system including a sensor device configured to sense a property of a mammal without physically contacting the mammal.
- the system also includes a signal generator configured to generate a signal indicative of the sensed property of the mammal.
- the system further describes a neuromodulation device configured to output a stimulus operable to modulate a nervous system component of the mammal in response to the signal indicative of the sensed property of the mammal.
- US2013/0245486 describes devices and methods that treat a medical condition, such as migraine headache, by electrically stimulating a nerve noninvasively, which may be a vagus nerve situated within a patient's neck.
- a nerve noninvasively which may be a vagus nerve situated within a patient's neck.
- Preferred embodiments allow a patient to self treat his or her condition.
- Disclosed methods assure that the device is being positioned correctly on the neck and that the amplitude and other parameters of the stimulation actually stimulate the vagus nerve with a therapeutic waveform. Those methods comprise measuring properties of the patient's larynx, pupil diameters, blood flow within an eye, electrodermal activity and/or heart rate variability.
- a major challenge in TMS is coil design, specifically creating coils that can appropriately stimulate deeper neuronal tissues whilst minimising stimulation in other areas, such as in the brain adjacent the scalp.
- This challenge is brought upon by the very physical laws that govern the electromagnetic fields as the magnetic field is inversely proportional to the square of the distance away from the coil.
- Some common designs of TMS coils include the circular coil, figure-of-8 coil, C-core coils, crown coil, and the H-coil. The suitability of the coil design depends on the application. For a surface level cortical stimulation, the circular and figure-of-8 coil are used, where the latter provides better focality. For deep brain stimulation (DBS) protocols, much bigger coil designs like the C-core, crown, and H-coils are used.
- the C-core coils also contain in them a high permeability iron core, which in turn strengthens the field, reduces heating, and minimises scalp stimulation.
- an aspect of the present invention seeks to provide an apparatus for providing sensory stimulation to a subject, the apparatus including: an input that acquires input signals indicative of a stimulatory input; a signal generator; a coil system including at least one coil; and, an electronic controller operating in accordance with software instructions that: receives the input signals from the input; performs analysis of the input signals; and, uses results of the analysis to cause the signal generator to generate stimulation signals, the stimulation signals being applied to the coil system to thereby generate a stimulatory electromagnetic field in a target region of the subject, the stimulatory electromagnetic field being configured to selectively activate sensory neurons to thereby stimulate the subject in accordance with the stimulatory input.
- the input includes: an input sensor that senses the stimulatory input; and, a wireless transceiver that receives the input signal from a remote device.
- the input sensor includes at least one of a microphone and an imaging device.
- the stimulatory input is audible
- the sensory neurons are spiral ganglion neurons.
- the stimulatory input is visual
- the sensory neurons are at least one of: retinal ganglion neurons; an optic nerve; a lateral geniculate nucleus; and a visual cortex.
- the stimulatory electromagnetic field is generated to minimise a magnitude of the stimulatory electromagnetic field outside the target region.
- the stimulatory electromagnetic field includes at least one of: a superposition of a plurality of electromagnetic fields; at least one inhomogeneous electromagnetic field; and, a sequence of electromagnetic fields.
- the coil system includes at least one of: at least two coils; at least three coils; at least four coils; less than ten coils; less than eight coils; and, at least one primary coil and at least one secondary coil.
- the coil system has a coil geometry arranged to focus electromagnetic fields from each of a plurality of coils on the target region.
- different ones of the plurality of coils are focused on different parts of the target region.
- the coil system includes a number of coils circumferentially spaced around an axis, the axis being coincident with the target region and the coils being arranged at an angle relative to the axis, so that ends of the coils face the target region.
- the coil system includes at least one coil coincident with the axis.
- the coil system includes at least one coil that is at least one of: a conical tapered coil; a dual lobe coil; a butterfly coil; a flat coil; a spiral coil; a helical coil; a multi layered helical coil; and, wound on a core.
- At least one winding of at least one coil has at least one of: an inner radius of at least one of: at least 0.2mm; at least 0.5mm; at least lmm; at least 5mm; at least lOmm; less than l.5mm; less then lOmm; less than l5mm; and, less than 20mm; and, an outer radius of at least one of: at least 5mm; at least 8mm; at least lOmm; at least 20mm; at least 30mm; and, less than 50mm; less than 60mm.
- the coil system includes at least one axial coil configured to generate an electric field in the target region.
- the axial coil includes a plurality of conductors extending along an axis of a coil geometry and wherein the coil geometry has a shape that is at least one of: a cone; a hemisphere; a concave hemisphere; a convex hemisphere; and, a cylinder.
- At least one coil is wound from a conductor at least one of: having a cross sectional area of at least one of: at least 0.00 lmm 2 ; at least 0.0 lmm 2 ; at least O. lmm 2 ; at least lmm 2 ; at least 5mm 2 ; at least lOmm 2 ; less than 20mm 2 ; and, less than l5mm 2 ; having a cross sectional shape of at least one of: round; and, rectangular; and, made from: a wire; a copper wire; and, a braided wire.
- the coil is wound about a core that is at least one of: an air core; a soft magnetic composite core; an insulated magnetic core; a laminated core; a high permeability magnetic core; and, a metal core.
- the core has at least one of: a radius of at least one of: at least 0.2mm; at least 0.5mm; at least lmm; at least 5mm; at least lOmm; less than l .5mm; less then lOmm; less than l5mm; and, less than 20mm; and, a length of at least one of: at least 0.5mm; at least 5mm; at least lOmm; at least l5mm; about 20mm-30mm; and, less than 40mm.
- the core tapers inwardly proximate an end of the core closest to the subject.
- apparatus includes at least one shield positioned adjacent the coil system to reduce stray fields.
- the at least one shield includes: a diamagnetic shield; a conductive shield; a shield positioned adjacent each coil; and, a shield positioned adjacent each coil, each shield including an opening having a radius of at least one of: at least 0.2mm; at least 0.5mm; about lmm; and, less than l .5mm.
- the apparatus includes a housing configured to be worn by the user.
- housing includes: a first coil system housing containing the coil system; and, a second processing component housing containing signal processing components.
- the apparatus includes a signal processor that at least partially processes the input sensor signals.
- the signal generator includes: a driver circuit that generates controlled drive signals in accordance with signals from the controller; and, a trigger circuit for each coil that uses the drive signals to generate the stimulation signals.
- the signal generator includes a power supply including a high voltage capacitive store that stores electrical charge for use by the trigger circuits.
- the signal generator includes an energy recovery circuitry.
- the apparatus includes a cooling system to cool the coils.
- the apparatus includes a response sensor that measures a response in the subject, and wherein the controller uses response signals from the response sensor to at least one of: generates the at least one stimulation signal; and, controls a position of coils in the coil array.
- the response sensor includes an electrical impedance tomography sensor.
- the electrical impedance tomography sensor includes: a plurality of electrodes in contact with a tissue of the subject proximate the target region; a signal generator that applies an alternating signals to a number of the plurality of electrodes; a signal sensor that measures electrical signals on other ones of the plurality of electrodes; and, one or more impedance processing devices configured to generate a map of the target region in accordance with the measured signals.
- the map is used to at least one of: position the at least one coil; and, control stimulation signals applied to the at least one coil.
- the system includes: a receiving coil configured to receive stray fields generated by the coil array; and, a charging system used to charge a battery using current generated by the receiving coil.
- the system includes a tuning circuit that tunes the receiving coil.
- the system includes a tuning circuit controller in communication with the electronic controller that controls the tuning circuit in accordance with the at least one stimulation signal.
- the controller generates a respective stimulation signal for each of a plurality of coils in the coil system.
- the apparatus includes an output for providing sensory stimulation to the subject.
- the stimulatory input is audible
- the output includes a speaker for providing auditory stimulation to the subject.
- the controller analyses the input sensor signals to determine one or more features; and, uses the features to generate one or more stimulation signals.
- the features include at least one of: features relating to a power of the acoustic signal at different frequencies; features relating to a change in power of the acoustic signal at different frequencies; features relating to a rate of change in power of the acoustic signal at different frequencies; time domain features; spectral features; cepstral features; wavelet features; Frequency coefficients; Mel Frequency Cepstral coefficients (MFCC); Gammatone Frequency Cepstral Coefficients (GFCC); GFCC delta; and, GFCC double delta.
- the controller uses the features and at least one computational model to generate the one or more stimulation signals, the computational model embodying relationships between the features and different stimulation signals.
- the at least one computational model is derived using at least one of: reference responses measured for reference subjects in response to reference stimulation signals generated using different features; reference responses measured for the subject in response to reference stimulation signals generated using different features; and, a model of at least the target region of the subject obtained from a 3D scan of the subject.
- the at least one computational model is derived by applying machine learning to the reference responses and reference stimulation signals.
- an aspect of the present invention seeks to provide a method for providing sensory stimulation to a subject, the method including: using an input to acquire input signals indicative of a stimulatory input; and, using an electronic controller operating in accordance with software instructions to: receive the input signals from the input; perform analysis of the input signals; and, use results of the analysis to cause a signal generator to generate stimulation signals, the stimulation signals being applied to a coil system to thereby generate a stimulatory electromagnetic field in a target region of the subject, the stimulatory electromagnetic field being configured to selectively activate sensory neurons to thereby stimulate the subject in accordance with the stimulatory input.
- an aspect of the present invention seeks to provide an apparatus for performing neuromodulation, the apparatus including: a signal generator; a coil system including at least one axial coil; and, an electronic controller operating in accordance with software instructions that: determines neuromodulation to be performed; and, causes the signal generator to generate modulation signals, the modulation signals being applied to the coil system to thereby generate a modulation electromagnetic field in a target region of the subject, the modulation electromagnetic field being configured to perform the neuromodulation.
- the axial coil includes a plurality of conductors extending along an axis of a coil geometry and wherein the coil geometry has a shape that is at least one of: a cone; a hemisphere; a concave hemisphere; a convex hemisphere; and, a cylinder.
- the controller is configured to determine the neuromodulation to be performed in accordance with at least one of: input signals received via an input; and, sensor signals received from a sensor.
- the input includes a wireless transceiver module.
- the controller is configured to select one of a number of defined modulation sequences stored in a memory.
- the coil system includes at least one of: at least two coils; at least three coils; at least four coils; less than ten coils; less than eight coils; and, at least one primary coil and at least one secondary coil.
- the coil system has a coil geometry arranged to focus electromagnetic fields from each of a plurality of coils on the target region.
- different ones of the plurality of coils are focused on different parts of the target region.
- the coil system includes a number of coils circumferentially spaced around an axis, the axis being coincident with the target region and the coils being arranged at an angle relative to the axis, so that ends of the coils face the target region.
- the coil system includes at least one coil coincident with the axis.
- At least one coil is wound from a conductor at least one of: having a cross sectional area of at least one of: at least 0.00 lmm 2 ; at least 0.0 lmm 2 ; at least O. lmm 2 ; at least lmm 2 ; at least 5mm 2 ; at least lOmm 2 ; less than 20mm 2 ; and, less than l5mm 2 ; having a cross sectional shape of at least one of: round; and, rectangular; and, made from: a wire; a copper wire; and, a braided wire.
- the coil is wound about a core that is at least one of: an air core; a soft magnetic composite core; an insulated magnetic core; a laminated core; a high permeability magnetic core; and, a metal core.
- the core has at least one of: a radius of at least one of: at least 0.2mm; at least 0.5mm; at least lmm; at least 5mm; at least lOmm; less than l .5mm; less then lOmm; less than l5mm; and, less than 20mm; and, a length of at least one of: at least 0.5mm; at least 5mm; at least lOmm; at least l5mm; about 20mm-30mm; and, less than 40mm.
- apparatus includes at least one shield positioned adjacent the coil system to reduce stray fields.
- the at least one shield includes: a diamagnetic shield; a conductive shield; a shield positioned adjacent each coil; and, a shield positioned adjacent each coil, each shield including an opening having a radius of at least one of: at least 0.2mm; at least 0.5mm; about lmm; and, less than l .5mm.
- the apparatus includes a housing configured to be worn by the user.
- housing includes: a first coil system housing containing the coil system; and, a second processing component housing containing signal processing components.
- the apparatus includes a signal processor that at least partially processes the input sensor signals.
- the signal generator includes: a driver circuit that generates controlled drive signals in accordance with signals from the controller; and, a trigger circuit for each coil that uses the drive signals to generate the stimulation signals.
- the signal generator includes a power supply including a high voltage capacitive store that stores electrical charge for use by the trigger circuits.
- the signal generator includes an energy recovery circuitry.
- the apparatus includes a cooling system to cool the coils.
- the apparatus includes a response sensor that measures a response in the subject, and wherein the controller uses response signals from the response sensor to at least one of: generates the at least one stimulation signal; and, controls a position of coils in the coil array.
- the response sensor includes an electrical impedance tomography sensor.
- the electrical impedance tomography sensor includes: a plurality of electrodes in contact with a tissue of the subject proximate the target region; a signal generator that applies an alternating signals to a number of the plurality of electrodes; a signal sensor that senses signals on other ones of the plurality of electrodes; and, one or more impedance processing devices configured to generate a map of the target region in accordance with signals from the signal sensor.
- the map is used to at least one of: position the at least one coil; and, control signals applied to the at least one coil.
- the system includes: a receiving coil configured to receive stray fields generated by the coil array; and, a charging system used to charge a battery using current generated by the receiving coil.
- the system includes a tuning circuit that tunes the receiving coil.
- the system includes a tuning circuit controller in communication with the electronic controller that controls the tuning circuit in accordance with the at least one stimulation signal.
- the controller generates a respective stimulation signal for each of a plurality of coils in the coil system.
- the modulation electromagnetic field is configured to provide at least one of: therapeutic stimulation to the target region of the subject; and, therapeutic inhibition to the target region of the subject.
- the neuromodulation is configured for treating Parkinson’s disease and wherein the target region includes: a subthalamic nucleus of the subject; a globus pallidus intemus of the subject; a ventral intermediate nucleus of the subject; and, a pedunculopontine nucleus of the subject.
- the neuromodulation is configured to provide therapy for essential tremor and wherein the target region includes a ventral intermediate nucleus of the subject. [0097] In one embodiment the neuromodulation is configured to provide therapy for dystonia where the target region is a globus pallidus intemus of the subject.
- the neuromodulation is configured to provide therapy for obsessive compulsive disorder and wherein the target region includes at least one of: a ventral capsule/ventral striatum of the subject; a nucleus accumbens of the subject; and a subthalamic nucleus of the subject.
- the neuromodulation is configured to provide pain therapy and wherein the target region is a primary motor cortex of the subject.
- the neuromodulation is configured to provide epilepsy therapy and wherein the target region includes internal capsules and regions of a thalamus of the subject.
- the target region includes a spinal cord of the subject and wherein the neuromodulation is configured to provide therapy for at least one of: refractory chronic pain; spinal cord injuries; failed back syndrome; complex regional pain syndrome; angina pectoris; ischemic limb pain; abdominal pain; intractable pain conditions; and overactive bladder syndrome.
- an aspect of the present invention seeks to provide a method for performing neuromodulation, the method including using an electronic controller operating in accordance with software instructions to: determine neuromodulation to be performed; and, cause a signal generator to generate modulation signals, the modulation signals being applied to a coil system including at least one axial coil configured to generate a modulation electromagnetic field in a target region of the subject, the modulation electromagnetic field being configured to perform the neuromodulation.
- Figure 1 is a schematic diagram of an example of an apparatus for providing sensory stimulation to a subject
- Figure 2 is a flowchart of an example of a method for providing sensory stimulation to a subject
- Figure 3 is a schematic diagram of a specific example of an apparatus for providing sensory stimulation to a subject
- Figure 4A is a schematic diagram of an example of the physical configuration of an apparatus for providing audible sensory stimulation
- Figure 4B is a schematic diagram of a further example of the physical configuration of an apparatus for providing audible sensory stimulation
- Figure 5 A is a schematic diagram of an example of the physical configuration of an apparatus for providing visual sensory stimulation
- Figure 5B is a schematic diagram of a second example of a physical configuration of an apparatus for providing visual sensory stimulation to a subject
- Figure 6 is a flowchart of a specific example of a method for providing sensory stimulation to a subject
- Figure 7 is a flowchart of an example of a method of generating a model
- Figures 8A and 8B are schematic positive and negative images showing the influence of a diamagnetic shield on the field generated by a coil
- Figure 9A is a schematic diagram of an example coil system configuration
- Figures 9B and 9C are schematic diagrams illustrating the electric fields generated in the subject using the coil system of Figure 9A;
- Figure 10A is a schematic diagram of an example of an alternative coil system configuration
- Figures 10B and 10C are schematic positive and negative images showing the electromagnetic fields generated by the coil system of Figure 10A;
- Figures 11A and 11B are schematic positive and negative images of a further example of a coil system configuration and the resulting electromagnetic fields
- Figures 11C and 11D are schematic positive and negative images showing the current density generated in the cochlea for the coil system configuration of Figures 11 A and 11B;
- Figures 12A and 12B are schematic positive and negative images of a further example of a coil system configuration and the resulting electromagnetic fields
- Figures l3A to 13C are schematic diagrams showing examples of the electromagnetic fields generated by example conical axial coils
- Figures 13D and 13E are schematic diagrams showing examples of the electromagnetic fields generated by coil arrays including a number of conical axial coils;
- Figure 13F is a schematic diagram showing an example of the electromagnetic field generated by a further example of a conical axial coil
- Figures 14A and 14B are schematic diagrams showing examples of the electromagnetic fields generated by example concave curved axial coils
- Figure 15 is a schematic diagram showing an example of the electromagnetic field generated by a further example of a convex curved axial coil
- Figures 16A and 16B are schematic diagrams showing examples of the electromagnetic fields generated by example cylindrical axial coils with a high permeability core;
- Figures 16C and 16D are schematic diagrams showing examples of the electromagnetic fields generated by example cylindrical axial coils without a high permeability core;
- Figures 16E and 16F are schematic diagrams showing examples of the electromagnetic fields generated by example conical axial coils without a high permeability core
- Figure 17A is a schematic diagram showing an example of the electromagnetic fields generated in the cochlea by an example coil array including cylindrical axial coils;
- Figure 17B is a schematic diagram showing an example of the electromagnetic fields generated in the cochlea by the coil array of Figure 17A;
- Figure 17C is a schematic side view of the coil array of Figure 17A in use
- Figure 17D is a schematic front view of the coil array of Figure 17A in use
- Figure 18A is a schematic perspective view of an example of a headset incorporating the coil array of Figure 17A;
- Figure 18B is a schematic perspective view of an example of a controller for the headset of Figure 18A;
- Figure 18C is a schematic side view of the headset of Figure 18A in use
- Figure 19A is a schematic diagram of an example of a stray field recovery system.
- Figure 19B is a schematic diagram of a specific example of an apparatus for providing sensory stimulation to a subject incorporating the stray field recovery system.
- the apparatus includes an input 101 that acquires input signals indicative of a stimulatory input.
- the nature of the input will vary depending upon the preferred implementation and a wide variety of different inputs could be used.
- the input is in the form of a sensor that operates to sense the stimulatory input, for example using a microphone or imaging device to capture audible or visual stimulatory inputs.
- the input could be a transceiver that receives an input signal from a remote device, such as a mobile phone, or the like, as will be described in more detail below.
- the apparatus includes a signal generator 107 coupled to a coil system, including one or more coils 111.
- the nature of the signal generator will vary depending upon the preferred implementation, but in one example the signal generator is a current source adapted to generate a varying current signal which is applied to the coils. This can include an amplifier or similar, or could include a capacitive store that can be discharged through the coils, as will be described in more detail below.
- the configuration of the coil system will vary depending on the sensory stimulation that is to be provided, although typically this will include a plurality of coils, such as spiral, multi-layered helical coils, or the like, optionally provided on respective cores, and further examples will be described in more detail below.
- the apparatus further includes an electronic controller 103 that operates in accordance with software instructions, typically stored in a memory, or the like, and operates to receive input signals from the input 101, and control the signal generated.
- an electronic controller 103 that operates in accordance with software instructions, typically stored in a memory, or the like, and operates to receive input signals from the input 101, and control the signal generated.
- the electronic controller is an integrated circuit or similar which is capable of processing input signals received from the input, analysing the input signals and controlling the signal generator.
- the controller could be any electronic processing device such as a microprocessor, microchip processor, logic gate configuration, firmware optionally associated with implementing logic such as an FPGA (Field Programmable Gate Array), or any other electronic device, system or arrangement.
- step 200 input signals are obtained by the input 101, either by sensing a sensory input, or receiving signals indicative of a sensory input from a remote device, such as a computer system, mobile phone or the like.
- a remote device such as a computer system, mobile phone or the like.
- the controller 103 analyses the input signals to ascertain the field(s) that needs to be generated by the coil system.
- the nature of the analysis that is performed will vary depending upon the preferred implementation, but typically this involves identifying particular features in the signals, such as features relating to the power of the signal at different frequencies, with these then being used either directly or indirectly to control the signal generator at step 220, thereby causing the signal to generate one or more stimulation signals.
- the stimulation signals are then applied to the coil system causing the coil system to generate a stimulatory electromagnetic field at step 230.
- the stimulatory electromagnetic field is generated in a target region of the subject so that it is sufficiently strong enough to activate sensory neurons in the target area, and thereby stimulate the subject in accordance with the stimulatory input.
- suitable control over the field(s) generated by the coil system allows for localisation of the stimulatory field to target individual groups of sensory neurons, in turn allowing different responses to be obtained. For example, this can be used to stimulate different neurons in the cochlea in a manner similar to a cochlear implant, thereby allowing different audible stimulus to be reproduced.
- the above described approach uses a electromagnetic field to stimulate sensory neurons non-invasively, using a stimulatory field of the required strength in a target area of the subject.
- a magnetic field generated by a coil is given by the Biot-Savart Law: [0151] Where B is the magnetic flux density generated due to a coil carrying the current /, m is the permeability of the matter and R is the displacement vector from the wire to the point where the field is calculated.
- H is the magnetic field intensity.
- the magnetic field can also be calculated using the magnetic vector potential:
- the first one is field induced due to the coil, and the second one is the field due to accumulation of charges at the tissue interface.
- a neuron typically contains a lipid bilayer membrane that contains within it embedded protein structures called ion channels. These ion channels act as gateways that connect the intracellular environment (cytoplasm) to the extracellular environment. These two environments contain many charged ionic species like Na + , K + , Ca 2+ , Cl and other organic ions, the concentrations of which vary depending on the type of the ion and its presence in the intracellular or extracellular environment. Due to these different concentrations, there is a resulting potential difference between the extracellular fluids and the cytoplasm. Typically, there is an accumulation of positive charges on the extracellular side of the lipid bilayer, and negative charges on the cytoplasm side of it.
- These ion concentrations and the potential difference are for the case when the neuron is passive, i.e. it is in a resting state, and this potential difference is called the equilibrium potential.
- This equilibrium potential for an ion X can be given by the Nemst Equation.
- R is the gas constant
- T is the temperature given in degrees Kelvin
- z is the valence of the ion
- F is Faraday Constant
- [X] 0 and [X]i are the concentrations of the ions outside and inside the cell respectively.
- Px refers to the permeability of the membrane to that ion in units of velocity cm/s.
- the ion channels can open or close due to a wide variety of triggers like voltage, mechanical force, light, and specific organic molecules, and their opening and closing comprise of the fundamental signal of neural communication called an action potential.
- the threshold for a giant squid axon lies towards the positive side of the resting potential of -70mV, i.e., it needs to move towards OmV.
- the sodium channels opens leading to a further depolarisation of the neuron. This results in a steep rise in the membrane potential. This triggers the potassium channels to open, and since there are more potassium ions in the cytoplasm, there is an outflux of potassium ions, which polarises the cell again.
- the cell is hyperpolarised, i.e. it goes below -70mV. It is then restored to the resting membrane potential through the ion pumps.
- This cascade of ion channels opening and closing results in a unique waveform of membrane potential, which is called the action potential.
- the stimulation method aims to elicit an action potential.
- the activation of a neuronal tissue is due to the interaction between the neuron and the electric field surrounding it.
- the electric field across a nerve fibre causes accumulation of further charges across the lipid bilayer. This leads to a potential difference, which once reaches the threshold, leads to the initiation of an action potential.
- this voltage change across the membrane due to the stimulus current is given by the following equation:
- V is the voltage
- Ii 0n is the ion current that can be calculated from appropriate membrane models
- L timuius is the stimulating current
- C m is the membrane capacitance.
- the neuronal structures can be modelled by the Hodgkin - Huxley model, and their response can be studied by the cable equation.
- E x is the axial component of the induced electric field
- V is the transmembrane voltage
- L is the space constant of the cable
- t is its time constant.
- UA x is the conductance of the ion channel for ion X.
- the electric field is not high because the fluids of the cochlea are highly dispersive. This dispersion occurs due to their high conductivity.
- the above described apparatus operates by utilising a coil system in order to generate a stimulatory electromagnetic field in a target region of the subject.
- the field selectively activates sensory neurons to thereby stimulate the subject in accordance with the stimulatory input.
- the coil system can be provided externally to the subject, this allows sensory stimulation of a subject without requiring an implanted device. This in turn avoids some of the disadvantages associated with implanted devices, including allowing temporary usage, avoiding damaging residual sensory perception, or the like.
- the techniques can be used in a wide range of different applications, including generating visual sensory input by stimulating the retinal ganglion neurons, an optic nerve, a lateral geniculate nucleus or a visual cortex.
- audible sensory input can be achieved by stimulating spiral ganglion neurons.
- Similar olfactory stimulation could also be generated through appropriate stimulation of the neurons in the olfactory bulb to elicit the sensation of smell in subjects with anosmia (impairment of smell), stimulation of the neurons in the taste pathways to elicit the sensation of taste, and the stimulation of vestibular neurons for people experiencing balance related ailments.
- the device can also be used on the somatosensory cortex to elicit the sensation of touch.
- the apparatus can be adapted to provide neurostimulation more generally, and is not limited to sensory stimulation.
- the input can include an input sensor, such as a microphone or imaging device that senses the audible or visual stimulatory input, with other suitable sensors being used for sensing taste, smell or touch inputs.
- an input sensor such as a microphone or imaging device that senses the audible or visual stimulatory input, with other suitable sensors being used for sensing taste, smell or touch inputs.
- a wireless transceiver such as a Wi-Fi or Bluetooth transceiver
- receives the input signal from a remote device such as a smart phone, computer system, or the like.
- a remote device such as a smart phone, computer system, or the like.
- This can be used to avoid issues associated with attempts to detect sounds in noisy environments, bypassing the environmental noise, and allowing the user to receive sound signals directly from the remote device.
- This can be used in an audible context to allow a subject to engage in telephone conversations, listen to music or the like.
- Similar techniques could also be used for other sensory inputs, for example to allow for direct visual stimulation based on computer content, such as presentations, virtual reality feeds, or the like.
- the coil system is configured in order to optimise the stimulatory electromagnetic field, and preferably in order to minimise stray fields so that the magnitude of the stimulatory electromagnetic field outside the target region is minimised, whilst maximising the field strength in the target region.
- the manner in which this is achieved will vary depending upon the preferred implementation but this typically involves using a coil system including at least two coils, at least three coils, at least four coils, and optionally less than ten or less than eight coils, optionally including one or more primary coils and one or more secondary coils. It will be appreciated however that this is not essential and any number of coils could be used.
- the use of multiple coils allows the stimulatory electromagnetic field to be generated using a superposition of a plurality of electromagnetic fields, each of which is generated using a respective coil, or a respective winding within a given coil.
- a superposition of fields is particularly advantageous, as this allows each individual field to have a lower magnitude, with a sufficiently strong stimulatory electromagnetic field only being generated in the target area where the fields overlap and constructively interfere.
- other techniques for field generation could be used, such as generating inhomogeneous electromagnetic fields and/or generating a sequence of electromagnetic fields. In this latter case, fields could be generated in a rapid sequence, so electric fields in the target region have not fully decayed before further fields are applied, with the electric fields combining to generate the required activation potential.
- the coil system further has a coil geometry arranged to focus electromagnetic fields from each of the coils on the target region. This typically involves providing a number of coils circumferentially spaced around an axis that is coincident with the target region, and with the coils being arranged at an angle relative to the axis so that ends of the coils face the target region. A further central coil may also be provided coincident with the axis. This configuration maximises the strength of the stimulatory electromagnetic field in the direction and at the depth of the target region.
- different ones of the plurality of coils can be focused on different parts of the target region, allowing different sensory responses to be triggered depending on which coils are activated.
- the coils may be movably mounted to a housing, to allow the coil position to be controlled dynamically, thereby ensuring the fields are focused on the target area, for example to counteract movement of a wearable device relative to the wearer.
- the physical configuration, including the position and orientation of the coils would typically be determined based on a 3D scan of the subject, impedance tomography mapping, or the like, to ensure the coils generate a stimulatory electromagnetic field correctly focused on the target region of the subject.
- the intensity and focus of the electromagnetic field is also dependent on the geometry of each individual coil, including the shape, number of windings, and wire diameter.
- the coil typically includes a spiral, multi-layered helical coil, wound on a core, although different configurations of coils can be used depending upon the particular configuration of the coil system and the location of the target region.
- the coil(s) could include conical tapered coils, including back-to-back tapered coils, dual lobed coils, such as figure of eight coils, butterfly coils, flat coils, spiral coils, helical coils, multi layered helical coils, or the like.
- the coils can be wound on a core such as an air core, a soft iron or magnetic composite core, metal core, an insulated or laminated core, a high permeability (typically over 10,000 H/m), or the like.
- the core can act to focus and/or strengthen the resulting electromagnetic field and typically has a radius of at least 0.2mm, at least 0.5mm, about lmm and less than l .5mm, and a length of at least 0.5mm, at least 5mm, at least lOmm, at least l5mm, about 20-30mm and less than 40mm, in order to produce a tightly focused field.
- At least one winding of at least one coil has an inner radius that is at least 0.2mm, at least 0.5mm, at least lmm, at least 5mm, at least lOmm, and typically less than l.5mm, less than lOmm, less than l5mm and less than 20mm.
- the coil typically has an outer radius of at least 5mm, at least 8mm, at least lOmm, at least 20mm, at least 300mm, less than 50mm and typically less than 60mm. It is found that these dimensions are both suitable for providing the required field strength, whilst avoiding the overall coil size from being unduly large and making the resulting coil system impractical from a use perspective.
- the coil system includes at least one axial coil.
- Axial coils typically include a plurality of conductors extending along an axis of a coil geometry, with a return path extending in a direction at least partially non-parallel to the axis, so that the coils generate an electric field in the target region.
- the main field generated is an electric field that extends outwardly from the coil aligned with the coil axis, which can help generate a more focused and/or higher strength field in a target region.
- this can be used to create electric fields in the target region.
- the coil axial coil typically includes a plurality of conductors extending along an axis of a coil geometry, with the coil geometry having a shape that is at a cone, a hemisphere, a concave hemisphere, a convex hemisphere or a cylinder, and examples will be described in more detail below.
- the coil is wound from a conductor having a cross sectional area of at least one of at least 0.00 lmm 2 , at least 0.0 lmm 2 , at least O. lmm 2 , at least lmm 2 , at least 5mm 2 , at least lOmm 2 , about 0.05mm 2 , less than 20mm 2 and less than l5mm 2 .
- a conductor having a cross sectional area of at least one of at least 0.00 lmm 2 , at least 0.0 lmm 2 , at least O. lmm 2 , at least lmm 2 , at least 5mm 2 , at least lOmm 2 , about 0.05mm 2 , less than 20mm 2 and less than l5mm 2 .
- the cross sectional area of the conductor per se has little impact on field strength
- using a smaller cross sectional area conductor results in a larger number of windings, which can in turn increase the strength of the resulting electromagnetic field. This however needs to be balanced by
- the conductor can have a round or rectangular shape, the latter of which can assist in maximising the conductor density for a given winding configuration.
- the conductor can be made from a wire, a copper wire, a braided wire, such as a braided Litz wire, or the like.
- the core can taper inwardly approximately an end of the core closest to the subject, which can help focus the generated electromagnetic field further, in turn helping minimise stray fields.
- Additional focussing can be obtained through the use of a shield formed from a diamagnetic or conductive material positioned adjacent the coil system.
- the shield can include a single shield but more typically includes a respective shield for each coil in the array, with the shield being positioned adjacent each coil, and including an opening having a radius of at least 0.2mm, at least 0.5mm, about lmm and less than l.5mm. Shielding can also be used to reduce external stray fields, which can assist in device usability.
- stray fields can be attenuated by recovering energy from the fields, which can in turn be used in order to at least partially power the apparatus, for example by charging a battery.
- the system further includes a receiving coil configured to receive stray fields generated by the coil array and a charging system used to charge a battery using current generated by the receiving coil.
- the ability of the receiving coil to scavenge energy from the stray fields will depend on the impedance of the receiving coils and the frequency of the fields generated by the coil array. Accordingly, in one example, the system includes a timing circuit that tunes the receiving coil, thereby optimising the recovery of energy from the stray field.
- the system includes a tuning circuit controller in communication with the electronic controller.
- the tuning circuit controller controls the tuning circuit in accordance with the at least one stimulation signal, so that the receiving coil and associated circuitry is optimised for the field currently being generated by the coil array.
- the apparatus typically further includes a housing configured to be worn by the user.
- the housing is formed in two parts, including a first coil system housing containing the coil system and a second processing component housing containing signal processing components, such as the controller and a power supply, such as rechargeable or replaceable batteries.
- the housing(s) is typically sealed to prevent ingress of water or other contaminants, and may be configured to conform to the subject for comfort.
- the housing could have a form factor similar to a pair of headphones and could include a cushion for comfort on the ear, and may include a securing means, such as a strap, headband and/or double sided adhesive tape, for firm positioning of the device on the ear.
- the system can also include a digital signal processor (DSP) that at least partially processes the input signals, for example to perform filtering or the like, which can help reduce subsequent downstream processing.
- DSP digital signal processor
- the signal generator includes a driver circuit that generates controlled drive signals in accordance with the signals from the controller and a trigger circuit for each coil that uses the drive signals to generate the stimulation signals.
- the trigger circuit can be coupled to a high voltage capacitive store that stores electrical charge so that a large current can discharged into the coils by the trigger circuit.
- the capacitive storage can be charged up to 2kV and optionally have a voltage rating of up to 7.5 kV. As a result of this high voltage, the current flowing through the coil can reach up to 8000A within several milliseconds, thereby allowing high strength electromagnetic fields to be generated, although it will be appreciated that lower currents may be used depending on the coil design.
- the apparatus can include energy recovery circuitry, which allows for a quick recharge following the discharge through the coil.
- the powering circuits can include power electronic components like MOSFETs, Thyristors and IGBTs that act as a switch to allow for the discharge of the capacitor bank into the coil, and can transfer up to 500 J energy in less than lOOms.
- the apparatus can also include circuitry that allows for the shaping of the stimulation signal pulse.
- the signal generator includes a cooling system that cools the coils.
- the cooling system can be of any appropriate form and may include a passive cooling system, such as radiative fins that conduct heat away from the coils and/or could include a liquid based cooling system which circulates a heat transfer medium through cooling pipes provided adjacent the coils.
- the apparatus can include a response sensor that measures a response in the subject, with the controller generating the stimulation signal or controlling a position of the coils, in accordance with response signals from the response sensor.
- the sensor can be used in order to provide feedback to help improve operation of the system, including dynamically adjusting stimulation signals, or controlling actuators to adjust a position of coils within the array.
- the nature of the response sensor can vary depending on the preferred implementation and could include a sensor for sensing resulting electric or electromagnetic fields, a sensor that senses a neuron response, a sensor that receives user input commands, for example to confirm a response to the stimulatory input, or the like.
- the response sensor includes an electrical impedance tomography sensor, which measures tissue impedance within or surrounding the target region.
- the impedance tomography sensor includes a plurality of electrodes in contact with a tissue of the subject proximate the target region and a signal generator that applies an alternating signals to a number of the plurality of electrodes.
- a signal sensor is used to measure electrical signals on other ones of the plurality of electrodes, with one or more impedance processing devices being provided to analyse the configured to generate a map of the target region in accordance with the measured signals.
- the generation of such impedance maps is known in the art and will not therefore be described in any detail.
- the map can be used to position the at least one coil and/or control stimulation signals applied to the at least one coil, thereby optimising operation of the system.
- the controller Whilst the same stimulation signal could be applied to each of the coils, more typically the controller generates a respective stimulation signal for each of the plurality of coils to thereby provide additional control over the superposed field, allowing more refined control over the activation of the sensory neurons, in turn improving the quality of the sensory stimulation.
- this can include adjusting the magnitude, frequency and/or phase of the stimulatory signals applied to each of the coils, allowing parameters of the resulting stimulatory electromagnetic field to be adjusted.
- this can be used to adjust a different focal point for the resulting stimulatory field, which in turn allows different neurons within the cochlea to be activated, in turn allowing different audible responses to be induced. It will be appreciated that a similar approach could also be used for other stimulatory inputs.
- the apparatus can include an output for providing sensory stimulation to the subject.
- the output can include a speaker, allowing sounds to be played back to the user. This can be performed in order to make use of any residual sensory capability, which can in turn increase the effectiveness of the stimulation process, and the ability of the subject to accurately perceive the sensory input.
- controller controls the signal generator will vary depending upon the preferred implementation. Typically, the controller analyses the input signals to determine one or more features with these features then being used to control the signal generator and generate the stimulation signals.
- the features can be extracted using known techniques, depending on the feature selected.
- the features can include any one or more of features relating to a power of the acoustic signal at different frequencies, features relating to a change in power of the acoustic signal at different frequencies, features relating to a rate of change in power of the acoustic signal at different frequencies, time domain features, spectral features, cepstral features, wavelet features, Frequency coefficients, Mel Frequency Cepstral coefficients (MFCC) and Gammatone Frequency Cepstral Coefficients (GFCC), GFCC delta and GFCC double delta features.
- MFCC Mel Frequency Cepstral coefficients
- GFCC Gammatone Frequency Cepstral Coefficients
- signal pre-processing could be performed, for pre-processing the acoustic signal by scaling, for example to emphasize or de-emphasize features, or by adding white noise, for example to adjust signal to noise characteristics.
- pattern recognition could be performed using transform methods, feature correlation, matched filtering, or the like.
- orthogonal decomposition, and Fourier representations could be used.
- Other encoding techniques such as edge extraction, and pattern feature codes for object recognition, could be used for spatial structures.
- features such as invariance coding, circular harmonic decomposition, log-polar methods, or the like, can be used.
- the controller uses the features and at least one computational model to generate the one or more stimulation signals.
- the computational model embodies relationships between the features and the different stimulation signals and can be derived in a variety of ways.
- the system can examine reference responses measured for one or more reference subjects, or the subject, in response to reference stimulation signals generated using different features. Additionally and/or alternatively, the system can examine a model of at least the target region of the subject obtained from a 3D scan of the subject, thereby allowing accurate targeting of the stimulatory fields within the target region of the subject.
- reference responses are collected from multiple subjects, and/or the current subject, in response to reference stimulation signals, with these being correlated with different features.
- This allows the effect of different stimulation signals to be understood, so that different stimulation signals can be applied based on different input signals, thereby allowing the required sensory response to be induced within the subject for a given stimulatory input.
- a base model can be established based on the response of a general population, with this then being customised on a per subject basis, for example taking into account results of the scan, as well as the feedback from the subject, so that the resulting fields are optimised for the particular subject.
- model Whilst derivation of the model could be performed manually utilising suitable statistical analysis, in practice the model is derived utilising a machine learning algorithm. In particular, this is typically performed by utilising the reference responses obtained for different stimulation signals, with this being used to train a computational model, so that the model reflects the stimulation signals that should be used to generate a desired stimulatory response.
- the nature of the model and the training performed can be of any appropriate form and could include any one or more of decision tree learning, random forest, logistic regression, association or learning, artificial neuron networks, deep learning, inductive logic programming, support vector machines, clustering, Bayesian networks, reinforcement learning, representation learning, similarity and metric learning, genetic algorithms, rule- based machine learning, learning classifier systems, or the like. As such schemes are known these will not be described in any further detail.
- the apparatus can be used to provide neuromodulation more broadly.
- the ability to provide neuromodulation is enhanced when using an axial coil, which can generate a more focused and/or higher strength field in a target region.
- the apparatus can again include a signal generator and a coil system including at least one axial coil, which typically includes a plurality of conductors extending along an axis of a coil geometry, and optionally has a coil geometry in the shape of a cone, a hemisphere, a concave hemisphere, a convex hemisphere, a cylinder, or the like.
- An electronic controller can be provided that determines neuromodulation to be performed and then causes the signal generator to generate modulation signals, the modulation signals being applied to the coil system to thereby generate a modulation electromagnetic field in a target region of the subject, the modulation electromagnetic field being configured to perform the neuromodulation.
- the apparatus does not necessarily require an input that acquires input signals indicative of a stimulatory input, but otherwise is largely similar to the apparatus described above with respect to Figure 1, and operates in a largely similar manner, albeit without requiring input signals to be received and analysed as described above with respect to steps 200 and 210 in Figure 2.
- the neuromodulation to be performed can be determined in other manners.
- an input such as a wireless transceiver module could be used to allow the neuromodulation to be performed to be controlled by a remote processing device, such as a computer system, smartphone, or the like.
- this could be performed based on sensor signals received from a sensor, or user input provided via a user interface, allowing a sensed parameter or user input to trigger the neuromodulation.
- the controller can be configured to select one of a number of defined modulation sequences stored in a memory, for example based on sensed parameters, allowing the device to be programmed with different sequences, and with an appropriate sequence being selected as needed.
- the apparatus can include features similar to those previously described.
- the apparatus can use multiple coils in the coil array, with the coil system including a coil geometry arranged to focus electromagnetic fields from each of a plurality of coils on the target region and/or different parts of the target region.
- the coil system can include a number of coils circumferentially spaced around an axis, the axis being coincident with the target region and the coils being arranged at an angle relative to the axis, so that ends of the coils face the target region, optionally including one coil coincident with the axis.
- the coils can be wound from a conductor having a variety of different cross sectional areas, and made from a wire, a copper wire, a braided wire, or the like.
- the coils can be wound about a core, such as an air core, a soft magnetic composite core, an insulated magnetic core, a laminated core, a high permeability magnetic core, a metal core, or the like.
- the apparatus can include at least one shield positioned adjacent the coil system to reduce stray fields and/or could include an energy recovery system to recover energy from the stray fields.
- the apparatus may include a housing configured to be worn by the user
- the apparatus can include a signal generator having a driver circuit that generates controlled drive signals in accordance with signals from the controller and a trigger circuit for each coil that uses the drive signals to generate the stimulation signals.
- the signal generator can include a power supply including a high voltage capacitive store that stores electrical charge for use by the trigger circuits, with an energy recovery circuitry optionally being provided.
- the system may include a cooling system to cool the coils.
- the apparatus can also include a response sensor, such as an impedance tomography sensor, which measures a response in the subject, allowing this to be used to control stimulation signals and/or a position of coils in the coil array. It will be appreciated that this can operate in a manner similar to that described above.
- a response sensor such as an impedance tomography sensor, which measures a response in the subject, allowing this to be used to control stimulation signals and/or a position of coils in the coil array. It will be appreciated that this can operate in a manner similar to that described above.
- Such an apparatus can be used to provide a range of different neuromodulation, including therapeutic stimulation and/or therapeutic inhibition.
- the apparatus can be configured for treating Parkinson’s disease, in which case the target region typically includes a subthalamic nucleus of the subject, a globus pallidus intemus of the subject, a ventral intermediate nucleus of the subject or a pedunculopontine nucleus of the subject.
- the target region typically includes a ventral intermediate nucleus of the subject, whereas providing therapy for dystonia can involve stimulating a globus pallidus intemus of the subject.
- the target region typically includes a ventral capsule/ventral striatum of the subject, a nucleus accumbens of the subject or a subthalamic nucleus of the subject.
- the target region is a primary motor cortex of the subject, whereas for epilepsy therapy, the target region includes internal capsules and regions of a thalamus of the subject.
- the target region can include a spinal cord of the subject, in which the neuromodulation is configured to provide therapy refractory chronic pain, spinal cord injuries, failed back syndrome, complex regional pain syndrome, angina pectoris, ischemic limb pain, abdominal pain, intractable pain conditions or overactive bladder syndrome.
- the neuromodulation is configured to provide therapy refractory chronic pain, spinal cord injuries, failed back syndrome, complex regional pain syndrome, angina pectoris, ischemic limb pain, abdominal pain, intractable pain conditions or overactive bladder syndrome.
- other therapies could additionally and/or alternatively be provided.
- the functional components typically include an input 301 such as a microphone, video camera, or the like.
- the input 301 is coupled to a digital signal processor 302, which is typically an integrated circuit configured to perform specific signal processing operations, such as digitising the input signal, performing frequency filtering, or the like.
- a processed signal is then output to controller 303, which is an electronic processing device, such as a microprocessor or similar.
- controller 303 is typically coupled to a memory 312, which stores software instructions for execution by the controller 303, allowing the controller 303 to process signals and control operation of the system.
- the apparatus further includes a power circuit 304 coupled to a power supply, such as a battery 313 or wireless supply, allowing power to be distributed to the digital signal processor 302, the controller 303, a driver circuit 307 and a voltage booster 305.
- a power supply such as a battery 313 or wireless supply
- the battery 313 could be coupled to an inductive or other charging system, allowing the battery to be charged as required.
- the voltage booster 305 is coupled to a capacitor 306, which operates to store charge, allowing this to be used by a trigger circuit 308 in order to generate a current that is applied to the coil system 311.
- a sensor 309 is provided which measures the response signal in the subject, by measuring electrical fields within the subject’s brain, with the resulting response signal undergoing processing by a signal processor 310 before being returned to the controller 303, to thereby provide feedback so that operation of the system can be adjusted to optimise performance.
- the controller 303 controls the signal processors 302, 310, and sends drive control signals to the driver 307, which in turn selectively activates the trigger circuit 308 causing stimulation signals to be applied to the coils.
- the apparatus can further include an amplifier and outlet, such as a speaker (not shown) in order to generate stimulation applied to the respective sensory organ, allowing any residual sense to be utilised to the extent possible.
- an amplified version of a received audible signal can be applied to the subject’s ear, so that the subject perceives an audible sensory response based on both their residual hearing and direct stimulation of their sensory neurons.
- the apparatus includes a first housing 421 that accommodates the coil system 311 and the input 301.
- the first housing 421 is typically in the form factor of a pair of headphones or similar which can be worn by the user.
- a second housing 422 is provided which accommodates the electrical components, including the controller, signal generator, and the like.
- the components in the second housing 422 are electrically coupled to the coils 311 in the coil system via a lead 423. It will be appreciated that this configuration keeps the control electronics remote to the coils, thereby avoiding interference by the heat and electromagnetic fields generated by the coils and the processing electronics.
- the device can be positioned on the external ear 431 with the ear canal 432, middle ear 433 and cochlea 434 being provided as shown, so that the coils are able to direct the generated stimulatory field towards the spiral ganglion neurons in the cochlea.
- the second housing 422 is shaped to fit behind the external ear as shown in the arrangement of Figure 4B.
- FIG. 5A and 5B An example of a system for providing visual stimulation is shown in Figures 5A and 5B.
- the system includes an input in the form of a camera 501 which is mounted on frames 524, which have a form factor similar to a pair of glasses.
- a first coil system housing 521 can project downwardly from the frame 524 in front of the eye thereby allowing the retinal ganglion neurons 535 to stimulated.
- processing electronics can be mounted in a second separate housing 522 connected via a lead 523 or could be integrated into the frame of the glasses as shown in Figure 5B.
- an input signal is obtained.
- the input signal is obtained from the input 301, passed to the signal processor 302 and controller 303 for processing.
- the signal processor 302 will typically perform pre-processing of the signal, for example to perform digitisation and filtering and optionally to determine spectral power features of the signal at step 610.
- MFCC features are used, which are widely known in audio signal processing, especially for human speech analysis. It will be appreciated however that other signal processing techniques and features could be used for other types of stimulation, such as visual stimulation.
- the process of generating the features generally involves using a filterbank to divide the frequency spectrum of the signal into multiple overlapping bands, which could be adjusted as required, and then calculating a log-energy based on a weighted sum of a Fast Fourier Transform (FFT) magnitude for each filter band.
- FFT Fast Fourier Transform
- a Discrete Cosine Transformation is applied to the sequence of log energies, thereby yielding a number of cepstral coefficients equal to the number of filters.
- DCT is a standard orthogonal transformation technique that results in the most important information about the spectrum being embedded in the lower order DCT coefficients.
- the DCT coefficients capture the energy variation across the entire spectrum, for example, the first DCT coefficient is the sum of all the log-energies. It will be appreciated that other transformations, such as discrete Hartley or Hilbert Transforms, could be used, and reference to DCT is not intended to be limiting.
- the controller 303 applies the features to a computational model stored in the memory 312, with the output of the model being used to determine drive control signals at step 630, which are transferred to the driver circuit 307, which in turn generates drive signals at step 640.
- the drive signals are used to activate the trigger circuit 308, which in turn discharges the capacitors 306 to generate the stimulatory signals at step 650.
- the stimulatory signals typically have defined phases, frequencies and magnitudes, which are applied to the coils to thereby generate the necessary stimulatory electromagnetic field, in particular allowing the focal point of the field to be controlled to generate the required stimulatory response in the subject.
- a response signal is measured by the response sensor 309, at step 660, with this then being transferred to the controller 303 to allow the controller 303 to perform dynamic adjustment of various settings at step 670, such as to control the magnitude of signals generated in the event that insufficient stimulation is obtained, or to tune the focal point of the field, for example to accommodate changes in the physical position of the coil system housing on the subject.
- reference stimulation signals are generated based on different features at step 700, with these being applied to reference subjects at step 710.
- reference responses are determined, either measuring these using the response sensor, and/or by interrogation of the subject, to understand the sensory response they perceive.
- a model is selected, with this being trained based on the features, the applied signals and the responses at step 740.
- the model is used to determine a relationship between features and stimulation signals that results in a desired stimulatory response that corresponds to inputs having the respective features. This allows a stimulation signals to be generated based on one or more features derived from the input signals.
- the nature of the model and the training performed can be of any appropriate form and could include any one or more of decision tree learning, random forest, logistic regression, association rule learning, artificial neural networks, deep learning, inductive logic programming, support vector machines, clustering, Bayesian networks, reinforcement learning, representation learning, similarity and metric learning, genetic algorithms, rule-based machine learning, learning classifier systems, or the like. As such schemes are known, these will not be described in any further detail.
- the process typically includes testing the model at step 750 to assess the discriminatory performance of the trained model.
- testing is typically performed using a subset of the reference data, and in particular, different reference responses to those used to train the model, to avoid model bias. The testing is used to ensure the computational model provides sufficient accuracy.
- the coil system will typically also be covered with a sheet of a highly conducting metal to shield other neurons in the head from getting stimulated due to being near the wire elements of the coils in the array.
- the shield can be either at the edges of the whole array, or around each coil.
- Figures 8 A and 8B illustrate the diamagnetic effect of a shield in the form of a superconductor sheet 811.2 over a coil 811.1, which shows how the field emanating from the coil is focused at an opening of the shield 811.2. This in turn results in a more focused field within the subject, specifically allowing the fields from different coils to be highly targeted towards the relevant sensor neurons.
- the shield can be made of a superconductor, diamagnetic material or the like, which in one example is made of Bismuth or the like.
- FIG. 9A A first example coil system arrangement for generating a stimulatory electromagnetic field in the cochlea is shown in Figure 9A.
- the coil system includes five core wound coils, including a single axial coil 911.1, and four circumferentially spaced coils 911.2, each of which face the cochlea.
- a non-core wound surface coil 911.3 is provided against the skull around an outer circumference of the core wound coils. This design results in appropriate levels of stimulation in the cochlea nerves (About 5V/m peak electric field for stimulation), which are shown in a simulated transverse cross section of the cochlea, as shown in Figures 9B and 9C.
- This coil arrangement uses a five-coil system with spiral helix windings along with a ferromagnetic core and including a single axial coil 1011.1, and four circumferentially spaced coils 1011.2, each of which face the cochlea. As shown in Figures 10B and 10C, there are high fields in the peripheral area due to this coil geometry as well, which is not ideal.
- Figures 11A and 11B demonstrate an idealistic positioning of three coils based on finite element computational simulations.
- the three coils 1111 are placed at 60 degrees from each other and the above brighter part is represented by two coils which are on the same XY plane, with the cochlea being highlighted by the white box 1134.
- Each coil is formed from a wire winding having a small diameter of 0.25 mm, wrapped in a spiral configuration, and extended over a helical configuration, to form a multi layered helical coil.
- At the center of the coil is a core with a high permeability material, which is of a diameter of 1 mm.
- the induced electric field is highest around the cochlea. This overcomes the disadvantage of a conventional TMS coil where the surface fields are higher than those at deeper levels inside the head. This focusing is possible due to the superposition of electromagnetic fields from each coil.
- Figures 11C and 11D show the current levels induced in the cochlea due to the coil arrangement of Figures 11A and 11B.
- the diagram illustrates the transverse cross section of the cochlea with a top view, and shows that the current levels in the cochlea at the maxima of the J distribution are sufficient to elicit action potential in the spiral ganglion neurons and thus would lead to the sensation of hearing.
- Changes in the focal point can be achieved by controlling the phase, amplitude, or frequency of the current in one or more coils in the array, thereby allowing different neurons within the cochlea to be stimulated and hence allowing different stimulatory responses to be achieved.
- FIG. 12A A further example arrangement for use in delivering visual stimulation is shown in Figures 12A and 12B.
- the coil arrangement uses single central primary coil 1211.1, and a number of smaller secondary coils 1211.2 circumferentially spaced around the primary coil 1211.1 to generate fields for stimulating the retinal ganglion cells 1234.
- one or more axial coils can be used.
- axial coils are designed to create and focus an electric field from the coil, instead of a magnetic field which is generated by the more traditional helical coil arrangements described above. As in previous design, it is the electric field that leads to the action potential, and hence direct generation of the electric field can be more effective in some circumstances.
- the helical coils can be more effective, primarily due to the relative permeability of biological tissues being almost the same as air, and the normal component of the magnetic field on the interaction between the surfaces of two media in contact staying the same. As a result there is typically lesser attenuation of the magnetic field, which leads to a higher induced electric field at the deep brain target. In contrast, electric fields tend to attenuate faster, as the normal component of electric field changes as it goes through the boundaries of two surfaces with different dielectric properties.
- the coil includes a plurality of conductors, formed from coil windings that pass along or adjacent to an axis of the coil geometry, with the windings extending through a periphery of the coil geometry, to maximise the current elements extending along the axis, and divert return paths away from the axis.
- the axial coil allows for maximum of dl elements along the axis of the coils, which produces a strong electric field in the axial direction.
- the part of the windings that return in order to complete the loop are placed to optimise focality and reduction of negative component of dl from them.
- This coil design creates an electric field which resembles in its distribution to a magnetic field produced by a helical coil. Thus, it is an optimum design to focus a stimulating electric field. It is also possible that an embodiment of the device will utilise a combination of coils with helical winding (all the configurations mentioned in the provisional) and coils with axial windings.
- Figures 13A to 13F demonstrate that an axial coil having a conical configuration can generate a significant electrical field in a target region offset from a cone tip, whilst a field magnitude is smaller behind the coil, leading to reduced stray fields. Furthermore, coil arrays including seven conical coils can generate sufficient electric fields in the cochlea, as shown in Figures 13D and 13E, to allow sensory action potentials to be induced.
- FIG. 17A to 17D A specific example of a coil array utilising cylindrical helical coils is shown in Figures 17A to 17D.
- the coil arrangement uses single central primary cylindrical axial coil 1711.1, and a number of smaller secondary cylindrical axial coils 1711.2 circumferentially spaced around the primary coil 1711.1 to generate fields for stimulating the cochlea 1734.
- each coil faces the cochlea, so that the generated electromagnetic fields are focused on the cochlea, as shown by the resulting field strengths within the cochlea. It will be appreciated that similar configurations can be implemented using axial coils.
- the system includes a headset 1820 including two first housings 1821, supported by a headband 1826.
- the first housings include front and rear lobes 1821.1, 1821.2, which sit in front and behind the subject’s ear E, with the front lobe 1821.1 incorporating the primary coil 1711.1 and the rear lobe 1821.2 incorporating the secondary coils 1711.2.
- a second housing 1822 is provided, which accommodates the electrical components, including the controller, signal generator, and the like.
- the second housing 1822 includes ports that connect to a lead 1823 extending from headset 1820 to electrically couple the coils 1711 to the control system.
- the second housing 1822 is coupled to a belt 1825, allowing this to be worn around the user’s waist.
- the system can generate a stray field close to the stimulating coil array, which can be recovered using a wireless charging mechanism, which will now be described in more detail with reference to Figures 19A and 19B.
- the system includes a coil array 1911 in communication with a controller 1916, which controls the frequency of stimulation signals applied via the coil array 1911.
- This is coupled to a first communications module 1917, which in turn communicates with a tuning system 1919 via a second communications module 1918, allowing the tuning system to be provided with information regarding the frequency of fields generated by the coil array 1911.
- the tuning system 1919 is coupled to a receiving coil 1914, allowing the impedance of the receiving coil 1914 to be tuned and thereby absorb as much energy as possible from the stray field.
- this arrangement uses a tightly coupled magnetic wireless charging mechanism to charge the system back with the magnetic field created in the superficial region of the stimulating coil.
- the transmitting coil is a high current TMS stimulating coil array 1911 and receiving coils 1914 are positioned between the primary coil and human head.
- Receiving coils will operate in resonant frequency of l20-l40kHz. Inductor-capacitor tank circuit is utilised to tune the frequency to increase the coupling factor.
- the magnetic field generated by the primary coil will be captured by the receiving coil then rectified, filtered distortions and the regulated before charging the battery.
- the stray electromagnetic field generated near the surface of stimulating coil array is captured by inductive charging receiving coils which is then rectified and filtered in power circuit before storing energy back in battery.
- the position and motion sensor such as optical position sensors or capacitive position sensors are introduced to continue monitoring the change in position of coil system and move back to the required position in the event of movement occurred.
- response sensors can be provided to determine feedback about the induced action potentials.
- this is achieved using a impedance tomography arrangement, which generates a map showing differences in the electrical conductivity of various biological tissues. This is achieved by applying alternating currents of one or multiple frequencies through electrodes, with a number of other electrodes measuring the resulting current or voltage induced within the subject.
- maps of equi-potentials to be used to create a 3D map of the target area.
- This system can enable the correct positioning of the various embodiments of the device, as changes in position of target tissues in the maps can be measured.
- This feedback can be either used to reposition the device before activation if the deviation is too high, or change the amount of electromagnetic fields emanating from the coils which would re-focus the fields on the target area in case of a small deviation.
- FIG. 19B An example of a control system including a charging system and response sensor system is shown in Figure 19B.
- the system includes an input 1901 such as a microphone, video camera, or the like.
- the input 1901 is coupled to a digital signal processor 1902, which is typically an integrated circuit configured to perform specific signal processing operations, such as digitising the input signal, performing frequency filtering, or the like.
- a processed signal is then output to controller 1903, which is an electronic processing device, such as a microprocessor or similar.
- controller 1903 is typically coupled to a memory 1912, which stores software instructions for execution by the controller 1903, allowing the controller 1903 to process signals and control operation of the system.
- the apparatus further includes a power circuit 1904 coupled to a power supply, such as a battery 1913 or wireless supply, allowing power to be distributed to the digital signal processor 1902, the controller 1903, a driver circuit 1907 and a voltage booster 1905.
- the battery 1913 could be coupled to an inductive or other charging system, allowing the battery to be charged as required.
- the power circuit 1904 is coupled to a receiving coil 1914, allowing recovered energy to be used to recharge the batter.
- a tuning circuit (not shown) would be provided as described in Figure 19A, allowing the receiving coil to be tuned as described above.
- the voltage booster 1905 is coupled to a capacitor 1906, which operates to store charge, allowing this to be used by a trigger circuit 1908 in order to generate a current that is applied to the coil system 1911.
- Impedance tomography sensor 1909 which measures the response signal in the subject, by measuring electrical fields within the subject’s brain, with the resulting response signal undergoing processing by a signal processor 1910 before being returned to the controller 1903, to thereby provide feedback so that operation of the system can be adjusted to optimise performance. Additionally, a position and control system 1915 can be used to adjust positioning of the coils in the coil array, and/or further refine control of the generated fields.
- the controller 1903 controls the signal processors 1902, 1910, and sends drive control signals to the driver 1907, which in turn selectively activates the trigger circuit 1908 causing stimulation signals to be applied to the coils.
- the apparatus can further include an amplifier and outlet, such as a speaker (not shown) in order to generate stimulation applied to the respective sensory organ, allowing any residual sense to be utilised to the extent possible.
- an amplifier and outlet such as a speaker (not shown) in order to generate stimulation applied to the respective sensory organ, allowing any residual sense to be utilised to the extent possible.
- an amplified version of a received audible signal can be applied to the subject’s ear, so that the subject perceives an audible sensory response based on both their residual hearing and direct stimulation of their sensory neurons.
- the above described system provides for the non-invasive stimulation of sensory neurons using electromagnetic pulses for the purpose of bypassing natural sensory mechanisms of the body in cases of sensory impairment such as loss of hearing, vision, smell, taste, touch, or balance.
- a cochlear implant usually contains multiple electrodes placed along the spiral of the cochlea. Each electrode targets a specific audio frequency range. This relates to the tonotopic mapping of the cochlea where the auditory information at 20,000 Hz is encoded at the base of the spiral and that of 20 Hz is encoded at the tip of the spiral.
- the electrodes of the cochlear implant are positioned so that they target the frequency ranges most associated with human voice leading to a better understanding of speech for the users. Since the cochlea fluids are conductive, the electrodes are activated one at a time. The above system utilises a similar strategy, using multiple coils in the array to generate fields that target different locations in the cochlea at different times to thereby generate a similar response.
- the system contains a coil system placed lateral (adjacent) to the external ear.
- Each coil in the array is focused at the cochlea, with each coil being designed to produce the maximum amount of electromagnetic field for a given spatial constraint on the coil geometry. This allows a superposed field to be created within the cochlea, with a focal point of peak field strength being movable, to allow different neurons to be stimulated, in a manner similar to that achieved by a cochlear implant, but without requiring the presence of electrodes within the cochlea.
- the above described arrangements can be used to provide a non-invasive hearing device. It will also be appreciated, however, that the techniques can be applied more broadly as an overall non-invasive sensory prosthesis.
- the same overall device can also be used for the non-invasive stimulation of retinal neurons, i.e. the retinal ganglion cells, which would enable people and other mammals with loss of vision due to causes in the periphery of the retinal neurons to see again. Similarly, this could be used to stimulate other senses, including touch, smell and taste.
- the device can also be used for augmented and virtual reality experiences, for example to provide additional sensory experiences in virtual reality.
- the input could include a microphone, camera, Bluetooth, wi-fi, a wireless telemetry system coupled with a discriminator, or an electronic chemical sensor for smell and taste.
- the system As also described above, as the system is capable of generating electromagnetic fields within a target region of the subject, the system can be used for neuromodulation more widely, and examples of this will now be described.
- FDA US Food and Drug Administration
- Deep Brain Stimulation techniques have been FDA approved for treating medically refractory Parkinson’s Disease, essential tremor, dystonia and obsessive-compulsive disorder (OCD). Other disease states are also under investigation, including Tourette’s syndrome, treatment-resistant depression, chronic pain, alcohol and drug addiction, cluster headaches and Alzheimer’s disease.
- Parkinson’s Disease is characterized as cardinal symptoms of tremor, rigidity, akinesia and bradykinesia, caused by the loss of dopamine cells in substantia nigra pars compacta.
- PD is thought to be of pathogenetic aetiology, specifically, due to mutations in alpha-synuclein, parkin, UCHL1, DJ1, PINK1, and LRRK2 genes.
- DJ1 and PINK1 express mitochondrial proteins involved in responses to oxidative stress and affect proteasomal function, and toxins related to the development of environment-induced PD also appear to affect the aforementioned mitochondrial functions, indicating a commonality in the factors contributing to the aetiopathogenesis of PD.
- Levodopa is the natural precursor of dopamine and can be taken orally to pass the blood brain barrier.
- Levodopa therapy can lead to significant adverse effects such as the“wearing off’ effect, levodopa-induced dyskinesias and other motor complications.
- PD pharmacological therapeutics include catechol-o-methyl-transferase inhibitors, dopamine agonists and non-dopaminergic therapy and may be used concomitantly with levodopa or each other.
- the neurosurgical treatment focusing on Deep Brain Stimulation (DBS), is also an optional therapy, however, is significantly more invasive due to the surgical nature of the intervention.
- DBS Deep Brain Stimulation
- Indications for DBS therapy for PD include motor fluctuations, dyskinesia, medication-refractory tremor and medical intolerance. Symptoms that respond well to dopamine medications are also effective targets for DBS therapy, such as resting tremor, rigidity, upper extremity bradykinesia and the bradykinetic component of gait. Some symptoms are worsened by DBS, however, and these include freezing of gait (FOG), dysarthria and dysphagia.
- FOG freezing of gait
- the ideal PD candidate for DBS therapy would exhibit L-dopa responsiveness assessed by the Unified Parkinson’s Disease Rating Scale, but also dopamine non-re sponsive tremor.
- the neuro-stimulatory DBS targets for PD are: the subthalamic nucleus (STN) at high frequency (l30Hz), which improves all cardinal symptoms of PD, but is associated with a decline of specific cognitive functions (i.e. verbal fluency, learning and memory); the globulus pallidus intemus (GPi) at high frequency (l30Hz), which has been shown to improve all cardinal symptoms of PD, without the greater cognitive decline of STN stimulation.
- STN subthalamic nucleus
- GPi globulus pallidus intemus
- ventrolateral intermedius can be stimulated using DBS to treat tremor symptoms of PD.
- the FOG symptom is worsened by DBS therapy, however, lowering the frequency of stimulation to 60Hz has produced fewer FOG episodes in PD patients.
- the pedunculopontine nucleus has also been demonstrated to be an effective alternative target for DBS, with reduced FOG episodes observed using this DBS target.
- Essential Tremor is one of the most underlying causes of action tremor, which manifests phenotypically as the inability to control the movement of body parts while actively moving.
- the tremor caused by essential tremor usually stays mild and stable more many years, however, may slowly worsen over time.
- the aetiology of essential tremor is not well understood, however, it is believed to have a strong genetic component with approximately 50% of people with essential tremor having a family member who also has tremor.
- Treatment of essential tremor is dependant on the severity of the tremor symptom. It may range from mild, where the patient is monitored by a doctor without treatment, to more severe forms, which require medical intervention. Additionally, stress and caffeine can worsen the effects of tremor and should be avoided.
- the medical interventions usually indicated for essential tremor include b-blockers (to control blood pressure), anticonvulsant medications and, if pharmacological therapeutics are ineffective, the neurosurgical route is taken usually in the form of DBS.
- Candidates for DBS therapy to treat essential tremor should be restricted to those with disabling action, postural, or rest tremors that significantly impact quality of life.
- the optimal nerve target for DBS intervention is the VIM, however, adverse events involving the development of dysarthria paresthesias have been observed due to the dissipation of current into the thalamic nucleus, posterior to the VIM, called ventralis caudalis (somatosensory thalamus).
- ventralis caudalis somatosensory thalamus
- One embodiment of our device will target the VIM to offer therapy to patients with essential tremor.
- the use of rTMS to stimulate this nerve will avoid the dissipation into the ventralis caudalis encountered with tDCS.
- Dystonia manifests as involuntary sustained muscle contraction and repetitive twisting movements, which over time result in abnormal posture.
- Dystonia is classified as focal, segmental, multifocal, generalized and hemidystonia.
- the aetiology of dystonia is can be classified as idiopathic (primary), hereditary (secondary) and trauma/secondary effects of diseases such as parkinsonian disorders and multiple sclerosis.
- Dystonia is also treated surgically by selective denervation of muscles, however, this has an inconsistent benefit.
- Physical therapies such as muscle strengthening and stretching as well as sensory training and limb- immobilization techniques have been trialled for limb dystonia but are currently of unproven benefit.
- An effective therapy for many neurological disorders is the use of botulinum toxin from C. botulinum, which inhibits the release of acetylcholine in into the neuromusclular junction.
- Botulinum toxin when injected into dystonic muscles, reduces muscle spasm, without systemic side effects.
- Botulinum is the treatment of choice for many classifications of dystonia, including cervical dystonia, blepharospasm, spasmodic dysphonia, oromandibular dystonia, and limb dystonia, as it provides long-term benefit to 70-90% of patients.
- DBS has been proposed as a novel therapy for dystonia, with the GPi being the target of choice.
- the effectiveness of GPi neurostimulation for the treatment of dystopia has been evaluated.
- the optic tract positioned just ventral to the GPi which can lead to visual defects if the electrode is not inserted at the right depth, the FDA approved GPi-DBS for the treatment of dystopia in 2003 via the HDE pathway.
- Obsessive Compulsive Disorder can be described as intrusive anxiety generating thoughts (obsessions) with repetitive behaviour or rituals (compulsions) perceived by the patient as necessary to reduce anxiety. OCD appears to be of complex, multifactorial aetiology. Neuroimaging studies have demonstrated that neuropathology of the basal-ganglia thalamocortical (BGTC) pathways, more specifically, in the prefrontal and limbic BGTC pathways.
- BGTC basal-ganglia thalamocortical
- OCD is usually treated pharmacologically using serotonin reuptake inhibitors (SRIs), which has shown to be largely effective in adults and moderately effective in children. Even with SRI medication, most treatment responders experience residual symptoms and are likely to relapse.
- SRIs serotonin reuptake inhibitors
- CBT Cognitive Behavioural Therapy
- DBS has shown promise in managing the symptoms of OCD, with bilateral DBS showing the highest effectiveness.
- the neuro-stimulatory DBS targets for OCD are: the ventral capsule/ventral striatum (VC/VS), which is related to mood alterations and was approved by the FDA in 2003 through the HDE pathway; the nucleus accumbens (NAc); the STN; and the inferior thalamic peduncle.
- VC/VS ventral capsule/ventral striatum
- NAc nucleus accumbens
- STN the inferior thalamic peduncle.
- MCS Motor Cortex Stimulation
- Epilepsy is a neurologic disorder that results in regularly occurring seizures, (partial or generalized) and can manifest in various ways, ranging from a person having a blank stare for a few seconds to incapacitating convulsions and loss of consciousness. Up to 30% of patients have treatment-refractory seizures that are unresponsive to antiepileptic drugs.
- DBS has been proposed as an alternative therapy to neurosurgery, as it is reversible and has demonstrated to significantly reduce the frequency of seizures.
- the neurostimulation targets for DBS to treat epilepsy and reduce the number of seizure episodes are the internal capsule and regions of the thalamus.
- NeuroPace R S system was approved by the FDA for the treatment of medically refractory epilepsy. This therapy reduced seizures by 37.9% compared to control initially, and 66% over 6 years. Patients also experienced an improved quality of life and cognitive functions, however, the mechanism of action has still not been elucidated by the literature.
- One embodiment of our device will target the internal capsule and regions of the thalamus to reduce the number of seizures in individuals with epilepsy.
- SCS Spinal Cord Stimulation
- Indications for the use of SCS for spinal cord injuries are: failed back surgery syndrome; complex regional pain syndrome; angina pectoris; ischemic limb pain; abdominal pain.
- a literature review has concluded that SCS is a safe and effective therapy for various intractable pain conditions, with a 68% decrease in chronic pain and continuous pain relief over a 24-month period.
- SCI Spinal cord injury
- Overactive bladder syndrome manifests as the involuntary contraction of the pelvic floor muscles and relaxation of the urinary sphincter muscles, leading to involuntary urination.
- Treatment for OBS is usually pharmacological or surgical in nature, however, the surgical path is quite dangerous.
- Neurostimulation of the S3 foramen has been observed to be a suitable therapy, however, complications arising from the implant act as a deterrent.
- Alternative to the S3 foramen SCS implant is percutaneous tibial nerve stimulation (PTNS).
- PTNS utilizes the nerve root S4 and is implanted closer to the skin, at the tibial nerve slightly above the ankle. The implant acts to stimulate the spinal nerve L4 through S3).
- Magnetic neurostimulation is also used, but not by the PTNS route.
- the described patent will utilize magnetic stimulation via the PTNS site (pw 200us @20Hz for 30 mins, once a week).
- VNS Vagus Nerve Stimulation
- the device is programmed to provide regular intervals of on and off stimulation, typically 30 seconds on and 5 minutes off. This is thought to work by increasing blood flow and metabolism in regions that are involved in the onset of epileptic seizures, though the precise mechanism of action is still under debate. As of 2002, there have been approximately 16,000 VNS implants to treat epilepsy.
- VNS For therapy-resistant depression, current treatments are of neurosurgical nature and are therefore highly invasive. The minimally-invasive nature of VNS has generated a lot of attention in the medical community, although the efficacy of VNS to treat therapy resistant- depression is still under debate.
- vagus nerve has been successfully stimulated at and near the mastoid bone tip, at the tip of the mastoid bone, via the neck, between the stemomastoid muscle and trachea.
- the most effective stimulation was performed by SHAFIK and colleagues, which used l75J/pulse at 40Hz frequency (10 seconds on, 10 seconds off, for 20 mins online and 60 mins offline, 5 times per subject), and this stimulation paradigm had the longest effect.
- Vagus nerve stimulation often co stimulates the phrenic nerve, so correct positioning/waveform can be manipulated to minimize co-stimulation of the phrenic nerve, as described for example in JP2008/081479A (YOSHIHOTO).
- VNS may be efficacious as a therapy for, including post-op ileus, TNA- dysfunction in Alzheimer’s disease and any other inflammation-related disease (which can be modulated by VNS).
- the practicality of VNS therefore, is not limited to disease states directly related to the vagus nerve, and can be used as a therapy for a variety of systemic conditions.
- Post-operative ileus or the inflammation of the small intestine, is extremely sensitive to surgery or other invasive therapies. It is best treated non-invasively using anti inflammatory medications/targeting the vagus nerve with magnetic stimulation.
- AD Alzheimer’s Disease
- a large proponent of the pathophysiological cycle of AD is the chronic inflammation which gives rise to the beta-amyloid protein and reduce tau protein clearing, resulting in cytokine secretion and further inflammation, worsening the progression of AD.
- Vagus neurostimulation has improved cognitive effects in AD patients, while also improving their pathophysiological profile, however, the mechanism for these effects are yet to be elucidated.
- POGD Post-op cognitive decline
- Rheumatoid arthritis is a disease with multiple aetiology, from genetics to trauma to various disease states. It is characterized by joint inflammation, and is usually treated by either physiotherapy and exercise or by disease-modifying antirheumatic drugs (DMARDS) used in combination with other drugs to manage underlying inflammation. DMARDS utilize the same pathway as neurostimulation, that is, TNFa-mediated inflammation by the vagus nerve. DMARDS have side-effects and, while usually mild in nature, can be quite significant in severity. Treating RA with a non-surgical route of therapy is optimal as surgery can induce further inflammation, worsening disease state.
- DARDS disease-modifying antirheumatic drugs
- COPD chronic obtrusive pulmonary disease
- the Sphincter of Oddi which is responsible for bile secretion, can also be modulated using neurostimulation to induce bile production and secretion.
- Different types of visual prosthesis include epiretinal, subretinal, suprachoroidal, optic nerve, LGN, and cortical implants.
- the current epiretinal prostheses consist of three components, which include a camera to capture light images, a processor to transform images into patterns of electrical stimulation, and an electrode array that sits on the inner surface of the retina and stimulates the remaining cells in the inner retina.
- Transchoroidal implants stimulate the retina from the outer part.
- the approach provides easier implantation with removed risk of retinal detachment or choroidal hemorrhage.
- An Australian initiative led by Bionic Vision Australia is developing suprachoroidal implants which evokes cortical activity by stimulating the retina from outside the sclera.
- the strategy has been efficient in different stimulation configurations such as monopolar and bipolar.
- Optic nerve is also a potential target for electrical stimulation because it conveys information of the entire visual field in a very small area. It is more challenging however, to focus the stimulation as there are more than a million axons contained in a 2mm diameter.
- Optic nerve prosthesis has been shown to elicit different phosphenes through a 4-contact cuff-electrode placed around the optic nerve that emits biphasic electrical pulses of varied amplitude, duration, frequency and number of pulses per phase.
- the lateral geniculate nucleus is also a potential site for visual prosthesis. It possesses the advantage of relatively simple cell segregation on an area that is larger than the retina, which allows for adaptation of image processing to the target area with a higher resolution. LGN stimulation in alert monkeys has shown the confirmed evocation of visual percepts and their spatial localization.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Radiology & Medical Imaging (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Theoretical Computer Science (AREA)
- Software Systems (AREA)
- Medical Informatics (AREA)
- Evolutionary Computation (AREA)
- Mathematical Physics (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Physics & Mathematics (AREA)
- Computing Systems (AREA)
- General Engineering & Computer Science (AREA)
- General Physics & Mathematics (AREA)
- Data Mining & Analysis (AREA)
- Artificial Intelligence (AREA)
- Business, Economics & Management (AREA)
- General Business, Economics & Management (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Magnetic Treatment Devices (AREA)
- Electrotherapy Devices (AREA)
Abstract
Description
Claims
Priority Applications (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19768149.7A EP3765148A4 (en) | 2018-03-13 | 2019-03-12 | Sensory stimulation apparatus |
| CN201980019081.0A CN112236194A (en) | 2018-03-13 | 2019-03-12 | sensory stimulation device |
| AU2019235608A AU2019235608A1 (en) | 2018-03-13 | 2019-03-12 | Sensory stimulation apparatus |
| US16/979,130 US20200398068A1 (en) | 2018-03-13 | 2019-03-12 | Sensory stimulation apparatus |
| JP2020572580A JP2021517502A (en) | 2018-03-13 | 2019-03-12 | Sensory stimulator |
| CA3093016A CA3093016A1 (en) | 2018-03-13 | 2019-03-12 | Sensory stimulation apparatus |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2018900824 | 2018-03-13 | ||
| AU2018900824A AU2018900824A0 (en) | 2018-03-13 | Sensory Stimulation Apparatus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2019173866A1 true WO2019173866A1 (en) | 2019-09-19 |
Family
ID=67907393
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/AU2019/050219 Ceased WO2019173866A1 (en) | 2018-03-13 | 2019-03-12 | Sensory stimulation apparatus |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20200398068A1 (en) |
| EP (1) | EP3765148A4 (en) |
| JP (1) | JP2021517502A (en) |
| CN (1) | CN112236194A (en) |
| AU (1) | AU2019235608A1 (en) |
| CA (1) | CA3093016A1 (en) |
| WO (1) | WO2019173866A1 (en) |
Cited By (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021074455A1 (en) * | 2019-10-18 | 2021-04-22 | Stimit Ag | Stimulation device and use thereof |
| DE202021104268U1 (en) | 2021-08-10 | 2021-08-13 | Biotronik Se & Co. Kg | Impedance tomography system for the alignment feedback of a charger for an implantable medical device |
| US11185690B2 (en) | 2016-05-23 | 2021-11-30 | BTL Healthcare Technologies, a.s. | Systems and methods for tissue treatment |
| US11247039B2 (en) | 2016-05-03 | 2022-02-15 | Btl Healthcare Technologies A.S. | Device including RF source of energy and vacuum system |
| US11247063B2 (en) | 2019-04-11 | 2022-02-15 | Btl Healthcare Technologies A.S. | Methods and devices for aesthetic treatment of biological structures by radiofrequency and magnetic energy |
| US11253718B2 (en) | 2015-07-01 | 2022-02-22 | Btl Healthcare Technologies A.S. | High power time varying magnetic field therapy |
| US11253717B2 (en) | 2015-10-29 | 2022-02-22 | Btl Healthcare Technologies A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US11266852B2 (en) | 2016-07-01 | 2022-03-08 | Btl Healthcare Technologies A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US11464993B2 (en) | 2016-05-03 | 2022-10-11 | Btl Healthcare Technologies A.S. | Device including RF source of energy and vacuum system |
| US11464994B2 (en) | 2016-05-10 | 2022-10-11 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US11484727B2 (en) | 2016-07-01 | 2022-11-01 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US11491342B2 (en) | 2015-07-01 | 2022-11-08 | Btl Medical Solutions A.S. | Magnetic stimulation methods and devices for therapeutic treatments |
| US11491329B2 (en) | 2020-05-04 | 2022-11-08 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
| US11534619B2 (en) | 2016-05-10 | 2022-12-27 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
| WO2023285503A2 (en) | 2021-07-14 | 2023-01-19 | Biotronik Se & Co. Kg | Impedance tomography system for alignment feedback of a charging device for an implantable medical device |
| US11612758B2 (en) | 2012-07-05 | 2023-03-28 | Btl Medical Solutions A.S. | Device for repetitive nerve stimulation in order to break down fat tissue means of inductive magnetic fields |
| US11633596B2 (en) | 2020-05-04 | 2023-04-25 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
| JP2023543739A (en) * | 2020-09-23 | 2023-10-18 | シュティミッツ アクチエンゲゼルシャフト | Stimulation device for stimulating nerves |
| EP4061481A4 (en) * | 2019-11-19 | 2023-12-20 | Bioretina Biyoteknoloji Ve Biyomedikal Saglik Yatirimlari Anonim Sirketi | CLINICAL AND PERSONAL ELECTROMAGNETIC STIMULATOR AND IONTOPHORESIS DEVICE FOR THE TREATMENT OF RETINAL AND OPTIC NERVE DISEASES |
| US11896816B2 (en) | 2021-11-03 | 2024-02-13 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
| US12064163B2 (en) | 2021-10-13 | 2024-08-20 | Btl Medical Solutions A.S. | Methods and devices for aesthetic treatment of biological structures by radiofrequency and magnetic energy |
| US12156689B2 (en) | 2019-04-11 | 2024-12-03 | Btl Medical Solutions A.S. | Methods and devices for aesthetic treatment of biological structures by radiofrequency and magnetic energy |
| EP4470606A1 (en) | 2023-05-30 | 2024-12-04 | Gbo Medizintechnik AG | Applicator device for applying magnetic fields for magnetic field therapy |
| US12274494B2 (en) | 2016-08-16 | 2025-04-15 | Btl Healthcare Technologies A.S. | Treatment device |
| US12558146B2 (en) | 2019-04-11 | 2026-02-24 | Btl Medical Solutions A.S. | Methods and devices for aesthetic treatment of biological structures by radiofrequency and magnetic energy |
| US12564726B1 (en) | 2024-10-08 | 2026-03-03 | Btl Medical Solutions A.S. | Devices and methods for application of a magnetic field to the nervous system |
| US12611545B2 (en) | 2020-05-04 | 2026-04-28 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014144785A1 (en) * | 2013-03-15 | 2014-09-18 | The Regents Of The University Of California | Multi-site transcutaneous electrical stimulation of the spinal cord for facilitation of locomotion |
| EP3824948A1 (en) | 2019-11-19 | 2021-05-26 | ONWARD Medical B.V. | A planning and/or control system for a neuromodulation system |
| DE19211738T1 (en) | 2019-11-27 | 2021-09-09 | Onward Medical B.V. | NEUROMODULATION SYSTEM |
| US12507930B2 (en) | 2020-03-23 | 2025-12-30 | Cornell University | Methods for selective activation of central thalamus fibers in a subject and systems therefor |
| CN113041501A (en) * | 2021-03-22 | 2021-06-29 | 东南大学 | Method for quickly resisting depression by combining magnetic stimulation system and targeting visual cortex |
| CN113040084B (en) * | 2021-03-23 | 2022-10-14 | 武汉大学 | Experimental device for analyzing influence of current field in water on fish behaviors |
| CN113554162B (en) * | 2021-07-23 | 2022-12-20 | 上海新氦类脑智能科技有限公司 | Axon input extension method, device, equipment and storage medium |
| CN113824193B (en) * | 2021-10-27 | 2023-05-23 | 四川大学 | Impedance matching method, apparatus, reinforcement learning controller, and computer-readable storage medium |
| KR102546063B1 (en) * | 2022-06-15 | 2023-06-21 | 주식회사 뉴로그린 | Stimulation providing apparatus |
| WO2024134662A1 (en) * | 2022-12-23 | 2024-06-27 | R Raman | A non-surgical hearing system and a method for providing sensory stimulation |
| US12623080B2 (en) | 2023-06-21 | 2026-05-12 | Onward Medical N.V. | Neuromodulation system |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013085924A1 (en) * | 2011-12-06 | 2013-06-13 | Lake Biosciences, Llc | Modulating function of neural structures near the ear |
| US20160144175A1 (en) * | 2009-03-20 | 2016-05-26 | ElectroCore, LLC | Medical self-treatment using non-invasive vagus nerve stimulation |
| US20170113042A1 (en) * | 2015-03-27 | 2017-04-27 | Elwha Llc | Controlling ear stimulation in response to image analysis |
| US20170266443A1 (en) * | 2006-10-02 | 2017-09-21 | Emkinetics, Inc. | Method and apparatus for transdermal stimulation over the palmar and plantar surfaces |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030195588A1 (en) * | 2002-04-16 | 2003-10-16 | Neuropace, Inc. | External ear canal interface for the treatment of neurological disorders |
| US20050154426A1 (en) * | 2002-05-09 | 2005-07-14 | Boveja Birinder R. | Method and system for providing therapy for neuropsychiatric and neurological disorders utilizing transcranical magnetic stimulation and pulsed electrical vagus nerve(s) stimulation |
| US7104947B2 (en) * | 2003-11-17 | 2006-09-12 | Neuronetics, Inc. | Determining stimulation levels for transcranial magnetic stimulation |
| US10286212B2 (en) * | 2009-03-20 | 2019-05-14 | Electrocore, Inc. | Nerve stimulation methods for averting imminent onset or episode of a disease |
| US9731142B2 (en) * | 2015-01-22 | 2017-08-15 | Cochlear Limited | Magnetic stimulation in tissue-stimulating prostheses |
| FR3031898B1 (en) * | 2015-01-28 | 2017-02-24 | Commissariat Energie Atomique | DEVICE AND METHOD FOR THE PROTHETIC REHABILITATION OF THE RETINA |
| US10603505B2 (en) * | 2017-06-07 | 2020-03-31 | Palo Alto Research Center Incorporated | Implantable neural probe |
-
2019
- 2019-03-12 JP JP2020572580A patent/JP2021517502A/en active Pending
- 2019-03-12 CA CA3093016A patent/CA3093016A1/en not_active Abandoned
- 2019-03-12 AU AU2019235608A patent/AU2019235608A1/en not_active Abandoned
- 2019-03-12 WO PCT/AU2019/050219 patent/WO2019173866A1/en not_active Ceased
- 2019-03-12 US US16/979,130 patent/US20200398068A1/en not_active Abandoned
- 2019-03-12 CN CN201980019081.0A patent/CN112236194A/en active Pending
- 2019-03-12 EP EP19768149.7A patent/EP3765148A4/en not_active Withdrawn
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20170266443A1 (en) * | 2006-10-02 | 2017-09-21 | Emkinetics, Inc. | Method and apparatus for transdermal stimulation over the palmar and plantar surfaces |
| US20160144175A1 (en) * | 2009-03-20 | 2016-05-26 | ElectroCore, LLC | Medical self-treatment using non-invasive vagus nerve stimulation |
| WO2013085924A1 (en) * | 2011-12-06 | 2013-06-13 | Lake Biosciences, Llc | Modulating function of neural structures near the ear |
| US20170113042A1 (en) * | 2015-03-27 | 2017-04-27 | Elwha Llc | Controlling ear stimulation in response to image analysis |
Non-Patent Citations (1)
| Title |
|---|
| See also references of EP3765148A4 * |
Cited By (62)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11612758B2 (en) | 2012-07-05 | 2023-03-28 | Btl Medical Solutions A.S. | Device for repetitive nerve stimulation in order to break down fat tissue means of inductive magnetic fields |
| US11253718B2 (en) | 2015-07-01 | 2022-02-22 | Btl Healthcare Technologies A.S. | High power time varying magnetic field therapy |
| US11491342B2 (en) | 2015-07-01 | 2022-11-08 | Btl Medical Solutions A.S. | Magnetic stimulation methods and devices for therapeutic treatments |
| US11266850B2 (en) | 2015-07-01 | 2022-03-08 | Btl Healthcare Technologies A.S. | High power time varying magnetic field therapy |
| US11253717B2 (en) | 2015-10-29 | 2022-02-22 | Btl Healthcare Technologies A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US11464993B2 (en) | 2016-05-03 | 2022-10-11 | Btl Healthcare Technologies A.S. | Device including RF source of energy and vacuum system |
| US11883643B2 (en) | 2016-05-03 | 2024-01-30 | Btl Healthcare Technologies A.S. | Systems and methods for treatment of a patient including RF and electrical energy |
| US11602629B2 (en) | 2016-05-03 | 2023-03-14 | Btl Healthcare Technologies A.S. | Systems and methods for treatment of a patient including rf and electrical energy |
| US11247039B2 (en) | 2016-05-03 | 2022-02-15 | Btl Healthcare Technologies A.S. | Device including RF source of energy and vacuum system |
| US12521562B2 (en) | 2016-05-03 | 2026-01-13 | Btl Healthcare Technologies A.S. | Device including RF source of energy and vacuum system |
| US11534619B2 (en) | 2016-05-10 | 2022-12-27 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US11464994B2 (en) | 2016-05-10 | 2022-10-11 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US12109426B2 (en) | 2016-05-10 | 2024-10-08 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US12589256B2 (en) | 2016-05-10 | 2026-03-31 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US11691024B2 (en) | 2016-05-10 | 2023-07-04 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US11590356B2 (en) | 2016-05-10 | 2023-02-28 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US12151120B2 (en) | 2016-05-10 | 2024-11-26 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US11896821B2 (en) | 2016-05-23 | 2024-02-13 | Btl Healthcare Technologies A.S. | Systems and methods for tissue treatment |
| US11185690B2 (en) | 2016-05-23 | 2021-11-30 | BTL Healthcare Technologies, a.s. | Systems and methods for tissue treatment |
| US11878162B2 (en) | 2016-05-23 | 2024-01-23 | Btl Healthcare Technologies A.S. | Systems and methods for tissue treatment |
| US11458307B2 (en) | 2016-05-23 | 2022-10-04 | Btl Healthcare Technologies A.S. | Systems and methods for tissue treatment |
| US11623083B2 (en) | 2016-05-23 | 2023-04-11 | Btl Healthcare Technologies A.S. | Systems and methods for tissue treatment |
| US11794029B2 (en) | 2016-07-01 | 2023-10-24 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US11266852B2 (en) | 2016-07-01 | 2022-03-08 | Btl Healthcare Technologies A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US12623088B2 (en) | 2016-07-01 | 2026-05-12 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US11628308B2 (en) | 2016-07-01 | 2023-04-18 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US12109427B2 (en) | 2016-07-01 | 2024-10-08 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US11497925B2 (en) | 2016-07-01 | 2022-11-15 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US11679270B2 (en) | 2016-07-01 | 2023-06-20 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US11524171B2 (en) | 2016-07-01 | 2022-12-13 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US12521565B2 (en) | 2016-07-01 | 2026-01-13 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US11607556B2 (en) | 2016-07-01 | 2023-03-21 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US11484727B2 (en) | 2016-07-01 | 2022-11-01 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US12274494B2 (en) | 2016-08-16 | 2025-04-15 | Btl Healthcare Technologies A.S. | Treatment device |
| US11247063B2 (en) | 2019-04-11 | 2022-02-15 | Btl Healthcare Technologies A.S. | Methods and devices for aesthetic treatment of biological structures by radiofrequency and magnetic energy |
| US11484725B2 (en) | 2019-04-11 | 2022-11-01 | Btl Medical Solutions A.S. | Methods and devices for aesthetic treatment of biological structures by radiofrequency and magnetic energy |
| US12156689B2 (en) | 2019-04-11 | 2024-12-03 | Btl Medical Solutions A.S. | Methods and devices for aesthetic treatment of biological structures by radiofrequency and magnetic energy |
| US12076576B2 (en) | 2019-04-11 | 2024-09-03 | Btl Medical Solutions A.S. | Methods and devices for aesthetic treatment of biological structures by radiofrequency and magnetic energy |
| US12558146B2 (en) | 2019-04-11 | 2026-02-24 | Btl Medical Solutions A.S. | Methods and devices for aesthetic treatment of biological structures by radiofrequency and magnetic energy |
| WO2021074455A1 (en) * | 2019-10-18 | 2021-04-22 | Stimit Ag | Stimulation device and use thereof |
| EP4061481A4 (en) * | 2019-11-19 | 2023-12-20 | Bioretina Biyoteknoloji Ve Biyomedikal Saglik Yatirimlari Anonim Sirketi | CLINICAL AND PERSONAL ELECTROMAGNETIC STIMULATOR AND IONTOPHORESIS DEVICE FOR THE TREATMENT OF RETINAL AND OPTIC NERVE DISEASES |
| US12029905B2 (en) | 2020-05-04 | 2024-07-09 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
| US12311170B2 (en) | 2020-05-04 | 2025-05-27 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
| US12611545B2 (en) | 2020-05-04 | 2026-04-28 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
| US11491329B2 (en) | 2020-05-04 | 2022-11-08 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
| US11878167B2 (en) | 2020-05-04 | 2024-01-23 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
| US12558542B2 (en) | 2020-05-04 | 2026-02-24 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
| US11826565B2 (en) | 2020-05-04 | 2023-11-28 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
| US11813451B2 (en) | 2020-05-04 | 2023-11-14 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
| US11633596B2 (en) | 2020-05-04 | 2023-04-25 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
| US11679255B2 (en) | 2020-05-04 | 2023-06-20 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
| US11806528B2 (en) | 2020-05-04 | 2023-11-07 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
| US12427307B2 (en) | 2020-05-04 | 2025-09-30 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
| JP2023543739A (en) * | 2020-09-23 | 2023-10-18 | シュティミッツ アクチエンゲゼルシャフト | Stimulation device for stimulating nerves |
| WO2023285503A2 (en) | 2021-07-14 | 2023-01-19 | Biotronik Se & Co. Kg | Impedance tomography system for alignment feedback of a charging device for an implantable medical device |
| DE202021104268U1 (en) | 2021-08-10 | 2021-08-13 | Biotronik Se & Co. Kg | Impedance tomography system for the alignment feedback of a charger for an implantable medical device |
| US12064163B2 (en) | 2021-10-13 | 2024-08-20 | Btl Medical Solutions A.S. | Methods and devices for aesthetic treatment of biological structures by radiofrequency and magnetic energy |
| US12115365B2 (en) | 2021-11-03 | 2024-10-15 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
| US11896816B2 (en) | 2021-11-03 | 2024-02-13 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
| WO2024245699A1 (en) | 2023-05-30 | 2024-12-05 | Gbo Medizintechnik Ag | Applicator device for applying magnetic fields for magnetic field therapy |
| EP4470606A1 (en) | 2023-05-30 | 2024-12-04 | Gbo Medizintechnik AG | Applicator device for applying magnetic fields for magnetic field therapy |
| US12564726B1 (en) | 2024-10-08 | 2026-03-03 | Btl Medical Solutions A.S. | Devices and methods for application of a magnetic field to the nervous system |
Also Published As
| Publication number | Publication date |
|---|---|
| CA3093016A1 (en) | 2019-09-19 |
| EP3765148A1 (en) | 2021-01-20 |
| CN112236194A (en) | 2021-01-15 |
| US20200398068A1 (en) | 2020-12-24 |
| JP2021517502A (en) | 2021-07-26 |
| AU2019235608A1 (en) | 2020-09-24 |
| EP3765148A4 (en) | 2022-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20200398068A1 (en) | Sensory stimulation apparatus | |
| JP6856704B2 (en) | Device for the treatment of medical disorders | |
| Nanduri et al. | Frequency and amplitude modulation have different effects on the percepts elicited by retinal stimulation | |
| US7801601B2 (en) | Controlling neuromodulation using stimulus modalities | |
| JP5858920B2 (en) | Trigeminal nerve stimulation system for treatment of neuropathy or pathology | |
| Wall Iii et al. | Vestibular prostheses: the engineering and biomedical issues | |
| CN103313754B (en) | Systems and methods for treating dry eye | |
| US8543211B2 (en) | Methods and apparatus for deep brain stimulation | |
| KR102425066B1 (en) | Customized tACS (transcranial Alternating Current Stimulation) Apparatus and Method for Stimulating a Brain wave by Entraining Synchronized Oscillation Based on Real-Time EEG Signal Monitoring | |
| JP2014506501A (en) | Apparatus, system, and method for targeted treatment of movement disorders | |
| WO2020150737A1 (en) | Methods and devices for modulation of integrated neural networks to influence composite sensory processes | |
| US20110190569A1 (en) | Non-invasive methods and devices for inducing euphoria in a patient and their therapeutic application | |
| AU2020256199B2 (en) | Device and method for wireless microstimulation | |
| De Ridder et al. | State of the art: novel applications for cortical stimulation | |
| US11623092B2 (en) | Implantable neurostimulator | |
| Danilov et al. | Translingual neurostimulation (TLNS): perspective on a novel approach to neurorehabilitation after brain injury | |
| WO2011109080A2 (en) | A device for intranasal and extranasal neuromodulation | |
| Glannon | Neural prosthetics: neuroscientific and philosophical aspects of changing the brain | |
| US12427303B2 (en) | Bioelectronic lens (e-lens) system for electrical stimulation and neuroprotection of the retina | |
| Berliner et al. | Cochlear implants: 1981 to 1985 | |
| Kuchta | Twenty-five years of auditory brainstem implants: perspectives | |
| Merfeld et al. | Vestibular prosthetics | |
| US20180178025A1 (en) | System and Method for Intracochlear and Vestibular Magnetic Stimulation | |
| US20250352816A1 (en) | Device and system for reduction of tinnitus defects and hearing disorders in the ear and to correct the defects along with real-time feedback with the help of brain output signal recording technology to determine the amount of corrections | |
| US20170333710A1 (en) | External Ear Nerve Stimulation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 19768149 Country of ref document: EP Kind code of ref document: A1 |
|
| ENP | Entry into the national phase |
Ref document number: 3093016 Country of ref document: CA |
|
| ENP | Entry into the national phase |
Ref document number: 2020572580 Country of ref document: JP Kind code of ref document: A |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| ENP | Entry into the national phase |
Ref document number: 2019235608 Country of ref document: AU Date of ref document: 20190312 Kind code of ref document: A |
|
| ENP | Entry into the national phase |
Ref document number: 2019768149 Country of ref document: EP Effective date: 20201013 |
